<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">NCP</journal-id>
<journal-id journal-id-type="hwp">spncp</journal-id>
<journal-id journal-id-type="nlm-ta">Nutr Clin Pract</journal-id>
<journal-title>Nutrition in Clinical Practice</journal-title>
<issn pub-type="ppub">0884-5336</issn>
<issn pub-type="epub">1941-2452</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0884533612454885</article-id>
<article-id pub-id-type="publisher-id">10.1177_0884533612454885</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Invited Reviews</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Diet and Nutrient Factors in Colorectal Cancer Risk</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Vargas</surname><given-names>Ashley J.</given-names></name>
<degrees>RD</degrees>
<xref ref-type="aff" rid="aff1-0884533612454885">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Thompson</surname><given-names>Patricia A.</given-names></name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff2-0884533612454885">2</xref>
</contrib>
</contrib-group>
<aff id="aff1-0884533612454885"><label>1</label>Department of Nutritional Sciences</aff>
<aff id="aff2-0884533612454885"><label>2</label>Department of Cellular and Molecular Medicine, University of Arizona Cancer Center, Tucson, Arizona</aff>
<author-notes>
<corresp id="corresp1-0884533612454885">Patricia A. Thompson, PhD, Department of Cellular and Molecular Medicine, University of Arizona Cancer Center, 1515 Campbell Ave, Cancer Prevention and Control, Tucson, AZ 85724; e-mail: <email>pthompson@azcc.arizona.edu</email>.</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>10</month>
<year>2012</year>
</pub-date>
<volume>27</volume>
<issue>5</issue>
<issue-title>Nutrition and Cancer</issue-title>
<fpage>613</fpage>
<lpage>623</lpage>
<permissions>
<copyright-statement>© 2012 American Society for Parenteral and Enteral Nutrition</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="society">The American Society for Parenteral and Enteral Nutrition</copyright-holder>
</permissions>
<abstract>
<p>Diet and nutrition are estimated to explain as much as 30%–50% of the worldwide incidence of colorectal cancer. In 2007, the World Cancer Research Fund (WCRF), in conjunction with the American Institute for Cancer Research (AICR), released the second expert report that summarizes the current scientific evidence linking diet to the prevention of cancer. This text provides an expert summary and level of evidence of the research relating diet/nutrients to factors that influence cancers of multiple organs, including colon and rectum, with an important emphasis on global patterns. Specific examples include dietary fat, red and processed meat, and dairy, as well effects of nutrients such as calcium, folate, and vitamin D. Evidence is obtained from ongoing systematic literature reviews conducted by experts in both the United States and Europe. The expert panel applies standard practices to evaluate the strength and quality of individual studies to draw summary conclusions. In 2011, the report was updated to include findings from a series of meta-analyses published in 2010. To complement the WCRF/AICR report, the authors review the evidence favoring the role for diet and nutrition in the etiology of colorectal cancer. Specifically, they have integrated information gained from more recent meta-analyses and high-quality, prospective study findings, some of which have been included in the 2011 updated WCRF/AICR summary.</p>
</abstract>
<kwd-group>
<kwd>colonic neoplasms</kwd>
<kwd>diet</kwd>
<kwd>food</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-0884533612454885">
<title>Global and Worldwide Cancer Incidence and Mortality</title>
<p>According to GLOBOCAN, ~600,000 deaths worldwide occur each year from colorectal cancer, making colorectal cancer the fourth cause of cancer deaths globally.<sup><xref ref-type="bibr" rid="bibr1-0884533612454885">1</xref></sup> For both incidence and mortality, men experience a higher burden of colorectal cancer than do women. Globally, cancer of the colorectum is the third most common cancer in men and the second most common in women. The incidence and mortality rates differ by as much as 10-fold with respect to geographic region and country, wherein more highly developed countries report the highest number of cases. The lowest age-adjusted incidence estimates are reported in regions of central Africa (eg, ~5.5/100,000 in the Central Republic of Africa and the Sudan) and south-central Asia (eg, ~4.3/100,000 in India). Central and South America report intermediate estimates (10-20/100,000), whereas Argentina and Uruguay approach estimates similar to those in many regions of the United States (30s/100,000). Higher incidence estimates come from western regions of Europe (~36-45/100,000) and Australia/New Zealand (~45/100,000). However, Eastern European countries continue to report the highest incidence, with the Czech Republic, Slovakia, and Hungary reporting the highest rates in the world (~50-60/100,000).</p>
<p>In the United States, approximately 1 in 20 people will experience a diagnosis of colorectal cancer. The 5-year relative survival rate for all stages of the disease is estimated at 64.3% from data derived between 2002 and 2008 from 18 of the contributing Surveillance Epidemiology and End Results (SEER) Cancer Registries.<sup><xref ref-type="bibr" rid="bibr2-0884533612454885">2</xref></sup> Furthermore, as summarized in <xref ref-type="table" rid="table1-0884533612454885">Table 1</xref>, incidence and mortality in the United States differ significantly by age, sex, and race.<sup><xref ref-type="bibr" rid="bibr3-0884533612454885">3</xref></sup></p>
<table-wrap id="table1-0884533612454885" position="float">
<label>Table 1.</label>
<caption><p>Incidence and Mortality of Colorectal Cancer Differ by Sex and Race/Ethnicity<sup><xref ref-type="bibr" rid="bibr3-0884533612454885">3</xref></sup></p></caption>
<graphic alternate-form-of="table1-0884533612454885" xlink:href="10.1177_0884533612454885-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
</colgroup>
<tbody>
<tr>
<td>• Incidence and mortality in men is 1.3- and 1.4-fold greater than that in women, respectively.</td>
</tr>
<tr>
<td>• Incidence is greatest in African American men (66.9/100,000), followed by non-Hispanic white men (53.1/100,000), with men of Asian American/Native American/Alaska Native/Hispanic descent having the lowest rates among men (45/100,000).</td>
</tr>
<tr>
<td>• Incidence rates for African American women (50.3/100,000) are similar to those in non-Hispanic white men.</td>
</tr>
<tr>
<td>• Mortality from colorectal cancer in African American men is 1.5-fold greater than that in non-Hispanic whites and 2-fold greater than that in Hispanic men.</td>
</tr>
<tr>
<td>• African American women have the highest mortality from colorectal cancer among women of all races, and Hispanic women have the lowest mortality from colorectal cancer, which is consistent with the lowest overall incidence in the population.</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>In recent years, the success of colorectal screening in the United States, which includes fecal occult blood testing and endoscopy procedures (sigmoidoscopy and colonoscopy), has resulted in earlier disease detection that has led to a significant ongoing reduction in both the incidence of, and mortality from, colorectal carcinoma.<sup><xref ref-type="bibr" rid="bibr4-0884533612454885">4</xref>,<xref ref-type="bibr" rid="bibr5-0884533612454885">5</xref></sup></p>
</sec>
<sec id="section2-0884533612454885">
<title>The Natural History of Colorectal Cancer and Opportunities for Prevention</title>
<p>The development of a model for the pathobiology of colorectal carcinogenesis, as a multistage process occurring over decades (illustrated in <xref ref-type="fig" rid="fig1-0884533612454885">Figure 1</xref>), largely accounts for the success achieved with screening and early detection. Colorectal tumors arise through a slow (years) series of transition states from normal colonic/rectal epithelium to adenomatous polyps. Exposure to tumor promoters and acquisition of additional genomic insults act to promote and progress these benign pathologies (tubular adenoma, tubulovillous/villous, and high-grade adenomas) to invasive and then metastatic carcinoma.<sup><xref ref-type="bibr" rid="bibr6-0884533612454885">6</xref></sup> If left undetected, a subset of these adenomatous polyps will develop into invasive carcinomas with the potential to metastasize to vital organs such as the liver, which is the most common site of distant metastasis leading to the death of patients. Given the protracted continuum of the pathology of colorectal carcinogenesis (years), there are a number of prevention opportunities along the continuum for which modification of diet and/or specific nutrients may modify risk. The successful implementation of diet- or nutrient-based prevention, however, requires an understanding of the role of nutrition in the causation, promotion, and progression of tumorigenesis in the colorectum.</p>
<fig id="fig1-0884533612454885" position="float">
<label>Figure 1.</label>
<caption><p>Multistep colorectal carcinogenesis model.</p></caption>
<graphic xlink:href="10.1177_0884533612454885-fig1.tif"/>
</fig>
</sec>
<sec id="section3-0884533612454885">
<title>The Role of Diet and Colorectal Cancer</title>
<p>Diet and nutrient factors are widely believed to act as pro- and antitumor risk modifiers across the entire multistep process of colorectal tumorigenesis, which includes tumor initiation, promotion, and progression.<sup><xref ref-type="bibr" rid="bibr7-0884533612454885">7</xref></sup> Differences in rates by country, and elevated risk among second and third generations of new migrants from a low- to high-risk country, strongly support environmental factors in colorectal cancer risk.<sup><xref ref-type="bibr" rid="bibr8-0884533612454885">8</xref><xref ref-type="bibr" rid="bibr9-0884533612454885"/><xref ref-type="bibr" rid="bibr10-0884533612454885"/><xref ref-type="bibr" rid="bibr11-0884533612454885"/>-<xref ref-type="bibr" rid="bibr12-0884533612454885">12</xref></sup> These significant differences overlay regionally distinct dietary patterns and are important in promoting the extensive number of animal, cell culture, and human studies that have been conducted to assess the effects of diet and nutrition in colorectal carcinogenesis. As a result, there exists a large body of scientific literature on which to evaluate and classify the level of evidence for a given nutrient, or dietary exposures, in relation to the risk of colorectal cancer.</p>
<p>Since there are a large number of studies (experimental, observational, and clinical), classification of a dietary or nutrition component as a “risk” or “protective” factor for colorectal carcinogenesis is weighted toward findings from randomized controlled trials (RCTs) in humans, when they exist, and well-conducted meta-analyses from large prospective studies when RCTs are not available. In addition, secondary evidence can be obtained from epidemiological studies where a consistently observed association between diet and cancer supports the potential for a relationship to exist. Furthermore, results from animal models provide insight into potential mechanisms of diet/nutrient effect and biological plausibility. Using these weighted criteria, the World Cancer Research Fund (WCRF)/American Institute for Cancer Research (AICR) developed 4 major categories to rank the level of evidence for individual dietary components: <italic>convincing, probable, limited but suggestive</italic>, and <italic>limited but not conclusive</italic> (see <xref ref-type="table" rid="table2-0884533612454885">Table 2</xref>).<sup><xref ref-type="bibr" rid="bibr13-0884533612454885">13</xref></sup></p>
<table-wrap id="table2-0884533612454885" position="float">
<label>Table 2.</label>
<caption><p>Dietary Exposures and Their Impact on Colorectal Cancer Risk by Direction, Level of Evidence, and Magnitude of the Effect</p></caption>
<graphic alternate-form-of="table2-0884533612454885" xlink:href="10.1177_0884533612454885-table2.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="left"/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Dietary Exposure</th>
<th align="center">Direction of Effect</th>
<th align="center">Level of Evidence</th>
<th align="center">Magnitude of Risk, %</th>
</tr>
</thead>
<tbody>
<tr>
<td>Red and processed meat</td>
<td>↑</td>
<td>Convincing</td>
<td>30–50</td>
</tr>
<tr>
<td>Supplemental calcium</td>
<td>↓</td>
<td>Probable</td>
<td>20</td>
</tr>
<tr>
<td>Excessive alcohol</td>
<td>↑</td>
<td>Convincing (men); probable (women)</td>
<td>8–52</td>
</tr>
<tr>
<td>Dietary fiber</td>
<td>↓</td>
<td>Probable</td>
<td>0–38</td>
</tr>
<tr>
<td>Milk/cheese</td>
<td>↓</td>
<td>Probable/limited, suggestive</td>
<td>2–17</td>
</tr>
<tr>
<td>Vitamin D</td>
<td>↓</td>
<td>Limited, suggestive</td>
<td>0–50</td>
</tr>
<tr>
<td>Dietary folate</td>
<td>↓</td>
<td>Limited, suggestive</td>
<td>8–15</td>
</tr>
<tr>
<td>Animal fats</td>
<td>↑</td>
<td>Limited, suggestive</td>
<td>0–20</td>
</tr>
<tr>
<td>Fish consumption</td>
<td>↓</td>
<td>Limited, suggestive</td>
<td>0–30</td>
</tr>
<tr>
<td>Fruits and vegetables</td>
<td>↓</td>
<td>Limited, suggestive</td>
<td>0–26</td>
</tr>
<tr>
<td>Selenium</td>
<td>↓</td>
<td>Limited, suggestive</td>
<td>0–25</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="section4-0884533612454885">
<title>Dietary Factors With Convincing Evidence as a Factor in Colorectal Cancer</title>
<sec id="section5-0884533612454885">
<title>Red and Processed Meat Consumption</title>
<p>A higher rate of colorectal cancer incidence among second- and third-generation migrants to the United States and other Western countries has been positively linked with change in the diet and lifestyle factors that are more prevalent in the adopted country.<sup><xref ref-type="bibr" rid="bibr11-0884533612454885">11</xref></sup> Increased red and processed meat consumption in more developed countries has been extensively studied as a cultural factor that may explain higher incidence rates in second and third generations of migrants originating from low-risk countries.<sup><xref ref-type="bibr" rid="bibr14-0884533612454885">14</xref></sup> Processed (nitrite-preserved) and red meats are both high in DNA-damaging N-nitroso compounds. Furthermore, red meat naturally contains high levels of heme, which is a known promoter of N-nitroso compounds and has been independently associated with increased risk of colorectal carcinoma.<sup><xref ref-type="bibr" rid="bibr15-0884533612454885">15</xref>,<xref ref-type="bibr" rid="bibr16-0884533612454885">16</xref></sup> There is also evidence in both biochemical and animal models that red meat cooked at high temperature (blackened or charbroiled) contains high levels of mutagenic heterocyclic amines, a class of probable colorectal carcinogens,<sup><xref ref-type="bibr" rid="bibr17-0884533612454885">17</xref><xref ref-type="bibr" rid="bibr18-0884533612454885"/><xref ref-type="bibr" rid="bibr19-0884533612454885"/>-<xref ref-type="bibr" rid="bibr20-0884533612454885">20</xref></sup> which may also alter bile acid and gut flora toward a more tumorigenic environment composition.<sup><xref ref-type="bibr" rid="bibr21-0884533612454885">21</xref><xref ref-type="bibr" rid="bibr22-0884533612454885"/>-<xref ref-type="bibr" rid="bibr23-0884533612454885">23</xref></sup> On the basis of (1) the consistency of the human data, (2) a risk relationship with the exposure dose, and (3) the strong biological plausibility, experts contributing to the WCRF/AICR concluded that higher intakes of processed and red meat are convincingly positively associated with colorectal cancer.</p>
<p>More recently, some authors challenged the WCRF/AICR conclusion citing the failure of studies that were reviewed to account for the presence of residual confounding from other lifestyle and dietary factors (a general challenge to epidemiological studies) and concern regarding the inconsistency of anatomical site-specific effects (ie, proximal colon, distal colon, or rectum) observed across different studies.<sup><xref ref-type="bibr" rid="bibr24-0884533612454885">24</xref></sup> In 2011, Chan et al<sup><xref ref-type="bibr" rid="bibr25-0884533612454885">25</xref></sup> published an updated meta-analysis of all prospective studies conducted from 1966 to March 2011. To draw an inference for the relationship between red and processed meat and colorectal cancer, Chan and colleagues considered the evidence for a dose-response relationship. In support of the WCRF/AICR original classification of red and processed meats, Chan et al reported that the risk of colorectal cancer increased by 29% for every 100 g/d of red meat and 21% for every 50 g/d of processed meat intake. However, the risk for colorectal cancer increased linearly only up to a total of ~140 g/d, when intakes of red and processed meats were combined. Overall, these results support a dose-response relationship and are consistent with the action of known carcinogens in animal models.</p>
</sec>
<sec id="section6-0884533612454885">
<title>Dietary Fiber</title>
<p>The observation that low colorectal cancer incidence and dietary patterns with high fiber content overlapped geographically led to Burkitt’s hypothesis that dietary fiber may decrease the risk of colorectal cancer.<sup><xref ref-type="bibr" rid="bibr26-0884533612454885">26</xref></sup> Many mechanisms by which fiber mitigates colorectal oncogenesis have been proposed. These include decreasing stool transit time (ie, more frequent stooling), altering gut flora and local metabolism, and general stool bulking.<sup><xref ref-type="bibr" rid="bibr22-0884533612454885">22</xref>,<xref ref-type="bibr" rid="bibr27-0884533612454885">27</xref><xref ref-type="bibr" rid="bibr28-0884533612454885"/>-<xref ref-type="bibr" rid="bibr29-0884533612454885">29</xref></sup> Despite promising modes of action, published studies are equivocal on fiber’s effects. Potential explanations for inconsistent findings across studies include confounding from other dietary factors that coexist with fiber in foods. Specifically, fruits, vegetables, and legumes are rich in both fiber and components with other anticancer activity.<sup><xref ref-type="bibr" rid="bibr30-0884533612454885">30</xref>,<xref ref-type="bibr" rid="bibr31-0884533612454885">31</xref></sup> Furthermore, it is likely that efficacy appears to differ by type or source of fiber.<sup><xref ref-type="bibr" rid="bibr29-0884533612454885">29</xref></sup></p>
<p>On the basis of the published literature at the time, the expert review conducted by the AICR/WCRF in 2007 found the evidence that fiber reduced colorectal cancer risk to be probable.<sup><xref ref-type="bibr" rid="bibr13-0884533612454885">13</xref></sup> In 2011, the evidence for the protective action of dietary fiber against colorectal cancer was raised to a “convincing” level by the AICR/WCRF as a more recent meta-analysis<sup><xref ref-type="bibr" rid="bibr32-0884533612454885">32</xref></sup> of 25 prospective studies found a 10% decrease in relative risk for developing colorectal cancer when consuming 10 g of total dietary fiber daily. Aune et al<sup><xref ref-type="bibr" rid="bibr32-0884533612454885">32</xref></sup> reported a 38% reduction in relative risk among individuals consuming legumes (eg, beans, alfalfa, peas, lentils, soy, and peanuts) as a primary source of dietary fiber. Furthermore, 3 servings of whole grains per day were associated with a 17% decreased risk of colorectal cancer.</p>
<p>Although results from the observational setting largely reflect an overall reduced risk of colorectal cancer with higher intakes of dietary fiber, results from the Wheat Bran Fiber RCT, which compared a cereal-based wheat bran fiber supplement with a low-fiber cereal, failed to show a risk-lowering effect for the development of colorectal adenoma in a polyp-forming patient population.<sup><xref ref-type="bibr" rid="bibr33-0884533612454885">33</xref></sup> A number of factors may explain the null findings, including the type of fiber, subject compliance, and potential lack of efficacy in an already high-risk, initiated population. Thus, other sources of fiber, including legumes (as suggested by Aune et al<sup><xref ref-type="bibr" rid="bibr32-0884533612454885">32</xref></sup>), as well as longer and/or earlier exposures to fiber need to be explored in the RCT setting.</p>
</sec>
</sec>
<sec id="section7-0884533612454885">
<title>Diet/Nutrient Factors With Probable Evidence for an Association With Colorectal Cancer</title>
<sec id="section8-0884533612454885">
<title>Dairy Products</title>
<p>In the WCRF/AICR report,<sup><xref ref-type="bibr" rid="bibr13-0884533612454885">13</xref></sup> milk but not cheese consumption was considered a “probable” protective dietary exposure for reducing the risk of colorectal cancer. This conclusion was recently supported by a systematic review and meta-analysis of 19 cohort studies.<sup><xref ref-type="bibr" rid="bibr34-0884533612454885">34</xref></sup> The reduced risk with higher intakes of milk has been attributed to a protective effect of calcium, and possibly vitamin D (discussed below), in the colorectum.</p>
<p>Experimental studies support a protective effect of calcium in colorectal carcinogenesis where calcium has been shown to bind to protumorigenic secondary bile acids and/or free fatty acids, which will reduce exposure of these putative carcinogens/toxicants to the lumen of the colorectum.<sup><xref ref-type="bibr" rid="bibr35-0884533612454885">35</xref>,<xref ref-type="bibr" rid="bibr36-0884533612454885">36</xref></sup> Concurrently, intracellular calcium has been shown to inhibit cell proliferation and promote colonic epithelial differentiation.<sup><xref ref-type="bibr" rid="bibr37-0884533612454885">37</xref></sup> Results from observational studies, however, have been highly inconsistent and are inherently challenged by the difficulty of separating the effects of calcium in foods from other dietary factors found in the food matrix. For example, many dairy products are a good source of calcium but also contain saturated fat, which is suspected to increase the risk of colorectal cancer (see Animal Fats). This is particularly difficult in human studies of cancer outcomes that rely on self-reported intakes.</p>
<p>The most compelling evidence supporting a protective effect of calcium comes from RCTs of supplemental calcium,<sup><xref ref-type="bibr" rid="bibr38-0884533612454885">38</xref></sup> where supplemental calcium is protective against the development of colorectal adenomatous polyps—the precursor lesion for colorectal cancers (see <xref ref-type="fig" rid="fig1-0884533612454885">Figure 1</xref>). In a recent meta-analysis of 3 RCTs, Carroll et al<sup><xref ref-type="bibr" rid="bibr39-0884533612454885">39</xref></sup> found that calcium exposure of 1200–2000 mg/d, alone or in combination with other micronutrients, was associated with a significant 20% reduction in the development of colorectal adenoma in patients with a history of colorectal adenomatous polyps. When stratified on baseline risk of developing a polyp, individuals with no elevated risk had no apparent benefit of supplemental calcium. Furthermore, it has been shown that the majority of the low-risk individuals were sufficient for calcium intake at study initiation and, therefore, less likely to have achieved any additional benefit from further supplementation. The observation of effects limited to only deficient/insufficient populations raises important issues about considering the baseline nutrition state of the individual before determining which diet/nutrient-based strategy would be most effective.</p>
<p>To date, no RCTs have been conducted in a solely calcium-deficient or calcium-insufficient population. Thus, the main conclusion that can be drawn from the evidence to date is that calcium supplementation is associated with a reduced risk of adenomatous polyps in higher risk, polyp formers. With the opposing effects of dietary fat and calcium in dairy products, an important alternative diet-based strategy is to encourage consumption of calcium-rich foods with low levels of saturated fats (eg, skim milk, low-fat cheeses, and yogurts). Given the benefits to bone health<sup><xref ref-type="bibr" rid="bibr40-0884533612454885">40</xref></sup> and possibly weight control,<sup><xref ref-type="bibr" rid="bibr41-0884533612454885">41</xref></sup> recommending a balanced whole-foods approach starting early in life with supplemental calcium would be ideal. Calcium supplementation should be reserved for patients with inadequate intakes and increased risk of colorectal cancer, to efficiently reduce the risk of colorectal cancer in the population.</p>
</sec>
<sec id="section9-0884533612454885">
<title>Alcohol Consumption</title>
<p>Ethanol, from fermented sugars, is a common dietary exposure in the adult population. A number of observational studies have reported a significant increased risk of colorectal cancer among heavy alcohol consumers.<sup><xref ref-type="bibr" rid="bibr42-0884533612454885">42</xref></sup> Although the exact mechanism of action for ethanol on the colorectum is unclear and likely multifactorial, several mechanistic hypotheses have been proposed: (1) ethanol is primarily oxidized to acetaldehyde, which can form DNA adducts and is generally genotoxic; (2) chronic alcohol exposure increases reactive oxygen species production via modulation of detoxification enzymes and other pathways that also create reactive species that interact with proteins and DNA; and (3) ethanol consumption depletes tetrahydrofolate levels, and excessive alcohol exposure leads to cellular hypomethylation (ie, folate-like deficiency).<sup><xref ref-type="bibr" rid="bibr43-0884533612454885">43</xref>,<xref ref-type="bibr" rid="bibr44-0884533612454885">44</xref></sup></p>
<p>Consistent with the conclusions of the WCRF/AICR report<sup><xref ref-type="bibr" rid="bibr13-0884533612454885">13</xref></sup> of a stronger association between alcohol and risk of colorectal cancer in men; a recent meta-analysis from Fedirko et al<sup><xref ref-type="bibr" rid="bibr42-0884533612454885">42</xref></sup> found that the relative risk of colorectal cancer was 21% and 52% higher for moderate (&gt;1–4 drinks/d) and heavy alcohol drinkers (≥4 drinks/d), respectively, when compared with nondrinkers/occasional drinkers. Furthermore, women who drank moderately had only an 8% increase in risk of colorectal cancer, whereas men had a 24% increase in risk when compared with nondrinkers/occasional drinkers. Upon expert review of the literature, there was convincing evidence and probable evidence for men and women, respectively, that alcohol had carcinogenic effects on the colorectum.<sup><xref ref-type="bibr" rid="bibr13-0884533612454885">13</xref></sup> The differential response by sex may be due to differences in exposure (ie, women consume less alcohol than men, on average) and/or sex-linked metabolic differences.</p>
<p>The effect of alcohol on colorectal cancer risk is not only sex specific; additional evidence supports an important role for the relative amounts of methyl donors in the diet. Specifically, increased alcohol intake combined with a methyl-poor diet (ie, low folate and methionine intake) increases the risk of developing colorectal neoplasms as compared with individuals who consume alcohol with methyl-rich diets.<sup><xref ref-type="bibr" rid="bibr45-0884533612454885">45</xref></sup> This observation further supports the hypotheses that epigenetic modification is a mechanism by which alcohol exerts a procarcinogenic effect in the colorectum. However, to our knowledge, the combined role of methyl donors, sex, and alcohol consumption on the risk of colorectal cancer has not been reported. These data do, however, confirm the need to consider more than one aspect of a patient’s diet. Specifically, healthcare practitioners should consider intake of methyl donors, folate status, and whether or not a patient is a regular and/or heavy consumer of alcohol when attempting to make recommendations.</p>
</sec>
</sec>
<sec id="section10-0884533612454885">
<title>Diet/Nutrient Factors With Limited, but Suggestive, Evidence for an Association With Colorectal Cancer</title>
<sec id="section11-0884533612454885">
<title>Dietary Folate</title>
<p>Folate, from the diet, and folic acid, from dietary supplements and food fortification, were first associated with decreased risk of colorectal cancer in large prospective observational studies.<sup><xref ref-type="bibr" rid="bibr46-0884533612454885">46</xref></sup> Folate/folic acid has been extensively studied for potential risk-lowering effects in the colorectum.</p>
<p>Both forms of folate/folic acid are endogenously metabolized to 5-methyl-tetrahydrofolate after absorption.<sup><xref ref-type="bibr" rid="bibr47-0884533612454885">47</xref></sup> 5-Methyl-tetrahydrofolate then enters the 1-carbon cycle and is required for maintaining DNA nucleotide synthesis while also serving as a critical methyl donor. Therefore, insufficient folate intake can lead to DNA damage, via uracil misincorporation or aberrant DNA repair, and epigenetic changes (ie, hypomethylation) that have been associated with colorectal carcinogenesis.<sup><xref ref-type="bibr" rid="bibr48-0884533612454885">48</xref></sup> Folate is interdependent on other methyl donors, such as methionine, and methyl group–depleting substances, such as alcohol. Therefore, the relative exposure to other nutrients (see Alcohol Consumption) may interact to influence risk.<sup><xref ref-type="bibr" rid="bibr49-0884533612454885">49</xref></sup> This complex interaction between nutrients and their codependence contributes to the challenge of isolating an effect to a single nutrient.</p>
<p>Despite a common endogenous metabolite, the joint AICR and WCRF global expert review panel found that only folate from foods and not synthetic folic acid had limited, suggestive evidence to link it to decreased risk of colorectal cancer.<sup><xref ref-type="bibr" rid="bibr13-0884533612454885">13</xref></sup> A subsequent systematic review of dietary folate found a 15% decrease in risk upon analysis of case-control studies and an 8% decrease in risk of colorectal cancer upon analysis of cohort studies in participants consuming above-average levels of dietary folate.<sup><xref ref-type="bibr" rid="bibr50-0884533612454885">50</xref></sup> Conversely, 3 meta-analyses of RCTs using folic acid for the prevention of colorectal adenoma found no significant beneficial effect of supplementation on adenoma risk and some evidence of a proneoplastic effect.<sup><xref ref-type="bibr" rid="bibr51-0884533612454885">51</xref>,<xref ref-type="bibr" rid="bibr52-0884533612454885">52</xref></sup> The possibility of a “U”-shaped effect of folic acid supplementation has been hypothesized to reflect differential effects of folate acting at different steps in carcinogenesis (ie, higher risk of colorectal cancer with insufficiency contributing to initiation while excessive folate exposure may contribute to promotion/progression where lesions have higher requirements for folate to support proliferation), which has led to questions about the immediate and long-term effects of folic acid fortification of the U.S. food supply that was mandated in 1998 in an effort to reduce neural tube defects.<sup><xref ref-type="bibr" rid="bibr53-0884533612454885">53</xref></sup> As of 2006, the majority (&gt;90%) of the U.S. population is replete in folate,<sup><xref ref-type="bibr" rid="bibr54-0884533612454885">54</xref></sup> which has led to questions about the necessity of continuing folic acid fortification. What remains unclear is whether high exposures early in life will manifest as a reduced risk, whereas higher exposures in older individuals may act to promote growth of initiated tissues.</p>
</sec>
<sec id="section12-0884533612454885">
<title>Animal Fats</title>
<p>The relationship between animal fat (which is predominately saturated fat) and colorectal cancer has consistently been challenged by the association with total dietary energy, other nutrients in the food matrix, and the residual confounding that remains after model adjustment.<sup><xref ref-type="bibr" rid="bibr55-0884533612454885">55</xref>,<xref ref-type="bibr" rid="bibr56-0884533612454885">56</xref></sup> In animal models, saturated fatty acids promote inflammation via production of prostaglandin E<sub>2</sub>,<sup><xref ref-type="bibr" rid="bibr57-0884533612454885">57</xref></sup> a mechanism of colorectal carcinogenesis that is well established in humans.<sup><xref ref-type="bibr" rid="bibr58-0884533612454885">58</xref></sup> In addition, saturated fats modify bile acid metabolism and alter gut flora composition toward a pro-oncogenic colon microenvironment.<sup><xref ref-type="bibr" rid="bibr59-0884533612454885">59</xref>,<xref ref-type="bibr" rid="bibr60-0884533612454885">60</xref></sup> However, despite strong experimental evidence, the AICR/WCRF concluded that findings from human studies were limited based on the lack of consistent results. Likewise, a 2009 meta-analysis found no evidence of an energy-independent, significant association between animal fats and the incidence of colorectal carcinoma.<sup><xref ref-type="bibr" rid="bibr61-0884533612454885">61</xref></sup> Moreover, the Women’s Health Initiative’s low-fat dietary intervention failed to demonstrate a reduction in risk of colorectal carcinomas, although the duration of the follow-up was likely insufficient to capture effects early in the tumorigenesis sequence and the diet intervention was not generally maintained for a long period.<sup><xref ref-type="bibr" rid="bibr62-0884533612454885">62</xref></sup> In contrast, recent results from the Dietary Approaches to Stop Hypertension Diet (DASH) Study, which emphasizes lower animal fat intake among other dietary changes, found a 20% reduction in the relative risk of colorectal cancer among adherent participants in more than 130,000 cohort participants.<sup><xref ref-type="bibr" rid="bibr63-0884533612454885">63</xref></sup> Overall, due to a lack of consistency in the findings from population and clinical trials, the link between dietary saturated fat intake and colorectal cancer remains only suggestive.<sup><xref ref-type="bibr" rid="bibr13-0884533612454885">13</xref></sup></p>
</sec>
<sec id="section13-0884533612454885">
<title>Fruits and Vegetables</title>
<p>The hypothesis that intake of vegetables and fruits reduces the risk of cancer originated more than 30 years ago and has generated a large number of studies to test this hypothesis.<sup><xref ref-type="bibr" rid="bibr64-0884533612454885">64</xref></sup> Both fruits and vegetables contain fiber, antioxidants, and other micronutrients with antitumor effects in experimental systems.<sup><xref ref-type="bibr" rid="bibr65-0884533612454885">65</xref></sup> Despite the longevity of this hypothesis, findings in human studies are highly inconsistent, and evidence is limited for a protective effect of fruits and vegetables in colorectal carcinogenesis.<sup><xref ref-type="bibr" rid="bibr13-0884533612454885">13</xref></sup> A recent meta-analysis of prospective studies considered in the recent 2011 update to the expert review found a 10%, 9%, and 8% reduction in risk of colorectal cancer for the highest intakes of fruits, vegetables, and their combination, respectively.<sup><xref ref-type="bibr" rid="bibr66-0884533612454885">66</xref></sup> These small effect sizes are generally consistent with predominantly null findings such as those from Koushik et al,<sup><xref ref-type="bibr" rid="bibr67-0884533612454885">67</xref></sup> who reported no significant overall effect of fruits, vegetables, and/or their combination for colorectal cancers. Discussion is ongoing for the potential benefit of these food groups by anatomic subsite of the colorectum. For example, Koushik et al reported a 26% reduced risk of cancer of the distal colon among participants with the highest intake of fruits and vegetables compared with the lowest. This effect was not seen in the proximal colon. In another study that assessed risk by subsite of the colorectum, analysis of 470,000 participants in European Prospective Investigation into Cancer and Nutrition (EPIC) revealed a 14% and 24% reduction in risk of colorectal and colon-only cancer risk, respectively, among individuals in the highest quintile of fruit and vegetable consumption.<sup><xref ref-type="bibr" rid="bibr68-0884533612454885">68</xref></sup> Overall, fruits and vegetables may act in the colon, and not the rectum, to reduce cancer risk, but further studies stratified by anatomic subsite and level of exposure are warranted to assess the consistency of these observations.</p>
</sec>
<sec id="section14-0884533612454885">
<title>Dietary and Supplemental Selenium</title>
<p>An extensive body of evidence from preclinical models and human studies supports selenium (Se) as a nutrient-based prevention strategy for colorectal cancer.<sup><xref ref-type="bibr" rid="bibr69-0884533612454885">69</xref></sup> Once ingested, Se is incorporated into specialized selenocysteine (Sec)–containing proteins or SEPs. In vitro,<sup><xref ref-type="bibr" rid="bibr70-0884533612454885">70</xref></sup> animal<sup><xref ref-type="bibr" rid="bibr71-0884533612454885">71</xref>,<xref ref-type="bibr" rid="bibr72-0884533612454885">72</xref></sup> and observational studies<sup><xref ref-type="bibr" rid="bibr73-0884533612454885">73</xref>,<xref ref-type="bibr" rid="bibr74-0884533612454885">74</xref></sup> support an anticancer effect of Se due to its role in SEPs.<sup><xref ref-type="bibr" rid="bibr73-0884533612454885">73</xref><xref ref-type="bibr" rid="bibr74-0884533612454885"/><xref ref-type="bibr" rid="bibr75-0884533612454885"/>-<xref ref-type="bibr" rid="bibr76-0884533612454885">76</xref></sup> The functions of SEPs include protection from oxidative DNA damage,<sup><xref ref-type="bibr" rid="bibr77-0884533612454885">77</xref></sup> induction of apoptosis,<sup><xref ref-type="bibr" rid="bibr78-0884533612454885">78</xref></sup> and effects on immune,<sup><xref ref-type="bibr" rid="bibr79-0884533612454885">79</xref></sup> thyroid,<sup><xref ref-type="bibr" rid="bibr80-0884533612454885">80</xref></sup> and insulin signaling.<sup><xref ref-type="bibr" rid="bibr81-0884533612454885">81</xref></sup> The profound redox abilities of SEPs also have critical signaling roles in inflammatory processes, particularly related to the oncogenic cyclooxygenase-2 pathway.<sup><xref ref-type="bibr" rid="bibr82-0884533612454885">82</xref><xref ref-type="bibr" rid="bibr83-0884533612454885"/>-<xref ref-type="bibr" rid="bibr84-0884533612454885">84</xref></sup> Of interest, Se compounds have been shown to prevent carcinogenesis in the intestines of murine models of colorectal cancer.<sup><xref ref-type="bibr" rid="bibr85-0884533612454885">85</xref>,<xref ref-type="bibr" rid="bibr86-0884533612454885">86</xref></sup></p>
<p>In support of a potential preventive effect of Se for colorectal adenoma development and the rationale for our ongoing randomized, placebo-controlled Se supplementation trial for the prevention of colorectal adenoma, data were pooled from 3 completed RCTs conducted throughout the 1990s.<sup><xref ref-type="bibr" rid="bibr87-0884533612454885">87</xref><xref ref-type="bibr" rid="bibr88-0884533612454885"/>-<xref ref-type="bibr" rid="bibr89-0884533612454885">89</xref></sup> Analyses of the pooled data show that individuals whose baseline plasma Se concentrations were in the highest quartile had 33% lower odds of developing adenomatous polyps of the colorectum over the course of the trials when compared with those in the lowest quartile.<sup><xref ref-type="bibr" rid="bibr90-0884533612454885">90</xref></sup> Results across the 3 individual studies were highly consistent. These results, combined with the preclinical mechanistic studies and presumed low toxicity of Se supplementation, have provided the scientific rationale for the ongoing RCT evaluating Se supplementation for the prevention of adenomatous polyps. However, results are not expected to be reported until late 2013 or early 2014. However, with the emergent concerns about adverse effects, including elevating the risk of diabetes, supplementation with Se in a Se- sufficient population is not currently recommended.<sup><xref ref-type="bibr" rid="bibr69-0884533612454885">69</xref></sup></p>
</sec>
<sec id="section15-0884533612454885">
<title>Dietary Vitamin D</title>
<p>In humans, the primary source of the fat-soluble hormone vitamin D is through the conversion of 7-dehydrocholesterol by exposure of the skin to ultraviolet irradiation, which generates the prohormone vitamin D<sub>3</sub> (cholecalciferol).<sup><xref ref-type="bibr" rid="bibr91-0884533612454885">91</xref></sup> Vitamin D<sub>3</sub> undergoes 2 hydroxylation steps to generate the active form; the first occurs in the liver, converting vitamin D<sub>3</sub> to 25-hydroxyvitamin D (25(OH)D) or calcidiol, with the second conversion occurring primarily in the kidney, where the active 1,25-dihydroxyvitamin D (1,25(OH)<sub>2</sub>D) or calcitriol is generated. In plants, the prohormone vitamin D<sub>2</sub> is derived from ergosterol, a sterol not found in vertebrates and land plants. Common foods sources of vitamin D<sub>3</sub> include fortified foods, such as milk, some yogurts, and cereals.<sup><xref ref-type="bibr" rid="bibr92-0884533612454885">92</xref></sup> Foods that naturally contain higher levels of vitamin D<sub>3</sub> include fatty fishes and fish oils. Fungi, like a number of mushroom species, are rich in vitamin D<sub>2</sub>. However, debate exists on the efficiency of D<sub>2</sub> to active hormone in animals as a substitute for vitamin D<sub>3</sub>.</p>
<p>In addition to being a major source of dietary calcium discussed above, milk consumption provides the major source of vitamin D in the population.<sup><xref ref-type="bibr" rid="bibr92-0884533612454885">92</xref></sup> Higher rates of colorectal cancer along more northern latitudes, where the population vitamin D levels are seasonally low, prompted an interest in vitamin D as a potentially important modifier of colorectal carcinogenesis.<sup><xref ref-type="bibr" rid="bibr93-0884533612454885">93</xref></sup> Vitamin D, like calcium, has demonstrated antitumor activity, including antiproliferative and prodifferentiating effects that are mediated through cell signaling and gene transcription, in model systems.<sup><xref ref-type="bibr" rid="bibr94-0884533612454885">94</xref></sup> Although lower vitamin D levels are more common among patients with colorectal cancer in some studies, the general consensus is that vitamin D is moderately protective against cancer in the colorectum. The beneficial levels of vitamin D, however, remain unknown, and relevance in replete populations remains controversial.<sup><xref ref-type="bibr" rid="bibr95-0884533612454885">95</xref></sup> The WCRF/AICR classified vitamin D as a “suggestive” protective factor for colorectal cancer, with the caveat that the data are currently insufficient. An ongoing, large phase III RCT designed to test the preventive efficacy of calcium and vitamin D supplementation in adenomatous polyp formers (high-risk population) will report in the next few years. Data from this study and other large ongoing trials will provide more insight into the putative protective effect of vitamin D. In addition, these studies will inform the scientific community on the significance of specific levels of circulating vitamin D<sub>3</sub> and will help to identify high-risk individuals using circulating vitamin D<sub>3</sub>.</p>
</sec>
<sec id="section16-0884533612454885">
<title>Fish Consumption</title>
<p>A great deal of interest in the potential protective role of high fish consumption for colorectal cancer has met with inconsistent evidence from human observational studies.<sup><xref ref-type="bibr" rid="bibr96-0884533612454885">96</xref></sup> As noted above, the fatty fish are enriched in vitamin D<sub>3</sub> as well as anti-inflammatory n-3 polyunsaturated fatty acids (PUFAs),<sup><xref ref-type="bibr" rid="bibr97-0884533612454885">97</xref></sup> which show protective activity in experimental models of colorectal carcinogenesis. A recently published meta-analysis by Wu et al<sup><xref ref-type="bibr" rid="bibr98-0884533612454885">98</xref></sup> that included 22 prospective cohort and 19 case-control studies on fish consumption and colorectal cancer risk reported an overall significant decrease in the risk of colorectal cancer by 12% (odds ratio [OR], 0.88; 95% confidence interval [CI], 0.80–0.95). When stratified on type of study (case-control or prospective cohort), the pooled ORs of colorectal cancer in the highest vs lowest fish intakes showed a consistent reduced risk (OR, 0.83; 95% CI, 0.72–0.95 and OR, 0.93; 95% CI, 0.86–1.01, respectively); however, the magnitude and significance of the effect were attenuated in the prospective studies. Interestingly, when the outcome was limited to the colon or rectum, the significant inverse association for fish intake was strongest for cancers of the rectum (~21% risk reduction), with a less profound effect of fish consumption on the colon. These results, as well as inconsistent findings across other studies, support the conclusion drawn by the WCRF/AICR report that the current evidence for fish consumption as protective against colorectal cancer is suggestive with limited evidence.</p>
</sec>
</sec>
<sec id="section17-0884533612454885">
<title>Diet and Nutrient Factors for Which the Evidence Is Too Limited to Draw Conclusions Regarding an Association With Colorectal Cancer</title>
<p>Numerous other dietary factors and nutrients are currently under investigation or are of continuing interest in nutrition and prevention science for their putative effects on colorectal carcinogenesis. A number of dietary factors and nutrients demonstrate active antitumor properties largely mediated through the inflammatory pathways.<sup><xref ref-type="bibr" rid="bibr99-0884533612454885">99</xref></sup> These include curcumin from the Indian curry spice tumeric and a number of the anthocyanin compounds found in red- and blue-colored fruits (eg, blueberries, raspberries, and cherries). In addition, the potent polyphenol in green tea, epigallectin (ECGC), has been reported to reduce the risk of adenomatous polyps with experimental data supporting potent activity on inflammation and angiogenesis.<sup><xref ref-type="bibr" rid="bibr100-0884533612454885">100</xref></sup> Active investigation in the human setting of a number of these bioactives from foods is ongoing. In general, the bodies of literature on these bioactives require further research in the following areas: evaluation of nutrient levels in whole foods, pharmacokinetics studies, bioactivity in vivo, and estimates of dietary levels in the general population. Importantly, the evolving investigation of the human gut microbiome with advanced sequencing technologies will shed critical insights on the complex role of the human diet in colorectal carcinogenesis that are likely mediated by direct effects of the diet on the protective or pathogenic nature of the gut flora.<sup><xref ref-type="bibr" rid="bibr101-0884533612454885">101</xref></sup></p>
</sec>
<sec id="section18-0884533612454885">
<title>Limitations of Dietary Association Studies</title>
<p>Inconsistency in the published literature regarding diet and colorectal cancer risk is the result of a number of limitations that challenge the field. These include but are not limited to the following factors: (1) Dietary components are most often estimated from self-report and can be highly confounded by a number of factors, making it difficult to isolate the effect of single nutrients or factors. (2) The effects of any individual dietary factor are usually of small magnitude, and consequently, a large population is required to see even small effects on disease risk. (3) Large RCTs are expensive and, therefore, prospective cohorts and other observational studies, which are challenged by sources of bias and confounding that cannot be controlled for, are our primary source of data on diet and disease. (4) In dietary RCTs that are not single nutrient based, compliance is difficult for many participants to achieve and maintain, which often results in regression of the intervention group toward the control. (5) Participants of large studies often are biased toward being healthy, which undermines a study’s ability to detect adverse effects of poor dietary habits. Other limitations of dietary assessment include the use of food frequency questionnaires, 24-hour dietary recalls, and other dietary measurement methodologies that rely on self-report of food intake. The use of self-report is prone to recall bias, portion size error, and limited specificity in the measurement tools (eg, specific brands/types of foods and method of food preparation that affects nutrient content).<sup><xref ref-type="bibr" rid="bibr102-0884533612454885">102</xref>,<xref ref-type="bibr" rid="bibr103-0884533612454885">103</xref></sup> However, the incorporation of biomarkers to calibrate dietary measurement (ie, doubly labeled water, urinary nitrogen, and specific nutrient levels) has improved our ability to correct for some levels of measurement error and increased the accuracy of the exposure estimates.<sup><xref ref-type="bibr" rid="bibr103-0884533612454885">103</xref></sup> In addition to measurement errors, dietary components exist in matrices with other potentially risk- modifying nutrients, making it hard to isolate the specific effects of a single nutrient. Along the same lines, although researchers can control for physical activity and energy intake statistically, residual confounding from these factors, which have been positively associated with risk of colorectal cancer, cannot be entirely excluded in many dietary association studies. Therefore, the results of dietary association studies should always be interpreted with caution.</p>
</sec>
<sec id="section19-0884533612454885">
<title>General Summary and Recommendations</title>
<p>Based on our current knowledge and level of confidence in the evidence, diet and nutrient recommendations for patients that can be made with confidence for lowering the risk of colorectal cancer include (1) moderating intake of red and processed meats; (2) cooking meats at a safe but lower temperature to avoid charring or blackening the meat; (3) moderating alcohol consumption, particularly for men; and (4) increasing plant-based sources of fiber, particularly consumption of legumes. With regard to fruits, vegetables, and diets rich in fish, these are generally recommended as part of a healthy diet and should be encouraged despite a lack of convincing data for a role in colorectal cancer prevention. Other factors, such as supplementation with nutrients such as vitamin D, selenium, and folate, are not currently supported by the data in human populations. Calcium is the only micronutrient for which we have sufficient evidence to recommend to patients who are at elevated risk for colorectal cancer but cannot achieve sufficient exposure through their diet. Because obesity and sedentary behavior are convincingly associated with risk of colorectal cancer,<sup><xref ref-type="bibr" rid="bibr104-0884533612454885">104</xref></sup> with emerging evidence for a dependence on disturbances in glucose regulation,<sup><xref ref-type="bibr" rid="bibr105-0884533612454885">105</xref></sup> avoidance of high caloric diets rich in sugars and fats is recommended. For example, a 2008 meta-analysis found significant associations between both glycemic index and load among individuals at increased of developing colorectal cancer risk.<sup><xref ref-type="bibr" rid="bibr105-0884533612454885">105</xref></sup> In contrast, however, a more recent meta-analysis did not find support for glycemic effects in the risk of colorectal carcinoma.<sup><xref ref-type="bibr" rid="bibr106-0884533612454885">106</xref></sup></p>
<p>In summary, on the basis of a patient’s medical and diet history, he or she should receive counseling toward energy- balanced diets rich in nutrient content from fruits, vegetables, nuts and grains, lean meats, legumes, and low-fat dairy products with low intake of sweetened beverages and food stuffs. In addition, care providers should consider a patient’s nutrition history, as well as his or her age, sex, and personal and family history of colorectal cancer in counseling regarding colorectal cancer screening and compliance with guidelines. Furthermore, although this review is specifically focused on the role of diet in relation to risk of developing colorectal cancer, it is important to note that regular physical activity has been consistently associated with a lower risk of colorectal cancer, whereas chronic excessive energy intake is a risk factor. Thus, it is important to recognize the complex interactions between patient behaviors and their dietary patterns in their risk of colorectal cancer. Consequently, any clinical counseling or public health message on nutrition and colorectal cancer prevention should include clear messaging on the importance of regular physical activity and energy balance in addition to the importance of dietary factors and nutrient intakes.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p>Financial disclosure: The University of Arizona Cancer Center Support Grant (P30CA023074)and Gastrointestinal SPORE Grant (P30CA023074)</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0884533612454885">
<label>1.</label>
<citation citation-type="web">
<collab>GLOBOCAN</collab>. <comment><ext-link ext-link-type="uri" xlink:href="http://globocan.iarc.fr/factsheets/cancers/colorectal.asp">http://globocan.iarc.fr/factsheets/cancers/colorectal.asp</ext-link></comment>. <access-date>Accessed April 1, 2012</access-date>, <year>2012</year>.</citation>
</ref>
<ref id="bibr2-0884533612454885">
<label>2.</label>
<citation citation-type="gov">
<person-group person-group-type="author">
<name><surname>Howlader</surname><given-names>N</given-names></name>
<name><surname>Noone</surname><given-names>AM</given-names></name>
<name><surname>Krapcho</surname><given-names>M</given-names></name>
<etal/>
</person-group>. <article-title>SEER cancer statistics review, 1975-2008</article-title>. <year>2011</year>. <comment><ext-link ext-link-type="uri" xlink:href="http://seer.cancer.gov/csr/1975_2008/">http://seer.cancer.gov/csr/1975_2008/</ext-link></comment>. <access-date>Accessed March 20, 2012</access-date>.</citation>
</ref>
<ref id="bibr3-0884533612454885">
<label>3.</label>
<citation citation-type="gov">
<collab>SEER stat fact sheets: colon and rectum</collab>. <source>SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations)</source>. <year>2011</year>. <comment><ext-link ext-link-type="uri" xlink:href="http://seer.cancer.gov/statfacts/html/colorect.html">http://seer.cancer.gov/statfacts/html/colorect.html</ext-link></comment>. <access-date>Accessed April 2012</access-date>.</citation>
</ref>
<ref id="bibr4-0884533612454885">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pignone</surname><given-names>M</given-names></name>
<name><surname>Rich</surname><given-names>M</given-names></name>
<name><surname>Teutsch</surname><given-names>SM</given-names></name>
<name><surname>Berg</surname><given-names>AO</given-names></name>
<name><surname>Lohr</surname><given-names>KN</given-names></name>
</person-group>. <article-title>Screening for colorectal cancer in adults at average risk: a summary of the evidence for the U.S. Preventive Services Task Force</article-title>. <source>Ann Intern Med</source>. <year>2002</year>;<volume>137</volume>(<issue>2</issue>):<fpage>132</fpage>-<lpage>141</lpage>.</citation>
</ref>
<ref id="bibr5-0884533612454885">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Siegel</surname><given-names>R</given-names></name>
<name><surname>Naishadham</surname><given-names>D</given-names></name>
<name><surname>Jemal</surname><given-names>A</given-names></name>
</person-group>. <article-title>Cancer statistics, 2012</article-title>. <source>CA Cancer J Clin</source>. <year>2012</year>;<volume>62</volume>(<issue>1</issue>):<fpage>10</fpage>-<lpage>29</lpage>.</citation>
</ref>
<ref id="bibr6-0884533612454885">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cappell</surname><given-names>MS</given-names></name>
</person-group>. <article-title>Pathophysiology, clinical presentation, and management of colon cancer</article-title>. <source>Gastroenterol Clin North Am</source>. <year>2008</year>;<volume>37</volume>(<issue>1</issue>):<fpage>1</fpage>-<lpage>24</lpage>.</citation>
</ref>
<ref id="bibr7-0884533612454885">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chan</surname><given-names>AT</given-names></name>
<name><surname>Giovannucci</surname><given-names>EL</given-names></name>
</person-group>. <article-title>Primary prevention of colorectal cancer</article-title>. <source>Gastroenterology</source>. <year>2010</year>;<volume>138</volume>(<issue>6</issue>):<fpage>2029</fpage>-<lpage>2043.e2010</lpage>.</citation>
</ref>
<ref id="bibr8-0884533612454885">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Flood</surname><given-names>DM</given-names></name>
<name><surname>Weiss</surname><given-names>NS</given-names></name>
<name><surname>Cook</surname><given-names>LS</given-names></name>
<name><surname>Emerson</surname><given-names>JC</given-names></name>
<name><surname>Schwartz</surname><given-names>SM</given-names></name>
<name><surname>Potter</surname><given-names>JD</given-names></name>
</person-group>. <article-title>Colorectal cancer incidence in Asian migrants to the United States and their descendants</article-title>. <source>Cancer Causes Control</source>. <year>2000</year>;<volume>11</volume>(<issue>5</issue>):<fpage>403</fpage>-<lpage>411</lpage>.</citation>
</ref>
<ref id="bibr9-0884533612454885">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Center</surname><given-names>MM</given-names></name>
<name><surname>Jemal</surname><given-names>A</given-names></name>
<name><surname>Smith</surname><given-names>RA</given-names></name>
<name><surname>Ward</surname><given-names>E</given-names></name>
</person-group>. <article-title>Worldwide variations in colorectal cancer</article-title>. <source>CA Cancer J Clin</source>. <year>2009</year>;<volume>59</volume>(<issue>6</issue>):<fpage>366</fpage>-<lpage>378</lpage>.</citation>
</ref>
<ref id="bibr10-0884533612454885">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Maskarinec</surname><given-names>G</given-names></name>
<name><surname>Noh</surname><given-names>JJ</given-names></name>
</person-group>. <article-title>The effect of migration on cancer incidence among Japanese in Hawaii</article-title>. <source>Ethn Dis</source>. <year>2004</year>;<volume>14</volume>(<issue>3</issue>):<fpage>431</fpage>-<lpage>439</lpage>.</citation>
</ref>
<ref id="bibr11-0884533612454885">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dunn</surname><given-names>JE</given-names></name>
</person-group>. <article-title>Cancer epidemiology in populations of the United States—with emphasis on Hawaii and California—and Japan</article-title>. <source>Cancer Res</source>. <year>1975</year>;<volume>35</volume>(<issue>11, pt 2</issue>):<fpage>3240</fpage>-<lpage>3245</lpage>.</citation>
</ref>
<ref id="bibr12-0884533612454885">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yu</surname><given-names>H</given-names></name>
<name><surname>Harris</surname><given-names>RE</given-names></name>
<name><surname>Gao</surname><given-names>Y-T</given-names></name>
<name><surname>Gao</surname><given-names>R</given-names></name>
<name><surname>Wynder</surname><given-names>EL</given-names></name>
</person-group>. <article-title>Comparative epidemiology of cancers of the colon, rectum, prostate and breast in Shanghai, China versus the United States</article-title>. <source>Int J Epidemiol</source>. <year>1991</year>;<volume>20</volume>(<issue>1</issue>):<fpage>76</fpage>-<lpage>81</lpage>.</citation>
</ref>
<ref id="bibr13-0884533612454885">
<label>13.</label>
<citation citation-type="book">
<collab>World Cancer Research Fund (WCRF)/American Institute for Cancer Research (AICR)</collab>. <source>Food, Nutrition, Physical Activity and the Prevention of Cancer: A Global Perspective</source>. <publisher-loc>Washington, DC</publisher-loc>: <publisher-name>AICR</publisher-name>; <year>2007</year>.</citation>
</ref>
<ref id="bibr14-0884533612454885">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Giovannucci</surname><given-names>E</given-names></name>
</person-group>. <article-title>Modifiable risk factors for colon cancer</article-title>. <source>Gastroenterol Clin North Am</source>. <year>2002</year>;<volume>31</volume>(<issue>4</issue>):<fpage>925</fpage>-<lpage>943</lpage>.</citation>
</ref>
<ref id="bibr15-0884533612454885">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cross</surname><given-names>AJ</given-names></name>
<name><surname>Pollock</surname><given-names>JR</given-names></name>
<name><surname>Bingham</surname><given-names>SA</given-names></name>
</person-group>. <article-title>Haem, not protein or inorganic iron, is responsible for endogenous intestinal N-nitrosation arising from red meat</article-title>. <source>Cancer Res</source>. <year>2003</year>;<volume>63</volume>(<issue>10</issue>):<fpage>2358</fpage>-<lpage>2360</lpage>.</citation>
</ref>
<ref id="bibr16-0884533612454885">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Santarelli</surname><given-names>RL</given-names></name>
<name><surname>Pierre</surname><given-names>F</given-names></name>
<name><surname>Corpet</surname><given-names>DE</given-names></name>
</person-group>. <article-title>Processed meat and colorectal cancer: a review of epidemiologic and experimental evidence</article-title>. <source>Nutr Cancer</source>. <year>2008</year>;<volume>60</volume>(<issue>2</issue>):<fpage>131</fpage>-<lpage>144</lpage>.</citation>
</ref>
<ref id="bibr17-0884533612454885">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bingham</surname><given-names>SA</given-names></name>
<name><surname>Pignatelli</surname><given-names>B</given-names></name>
<name><surname>Pollock</surname><given-names>JRA</given-names></name>
<etal/>
</person-group>. <article-title>Does increased endogenous formation of N-nitroso compounds in the human colon explain the association between red meat and colon cancer?</article-title> <source>Carcinogenesis</source>. <year>1996</year>;<volume>17</volume>(<issue>3</issue>):<fpage>515</fpage>-<lpage>523</lpage>.</citation>
</ref>
<ref id="bibr18-0884533612454885">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Joosen</surname><given-names>AMCP</given-names></name>
<name><surname>Kuhnle</surname><given-names>GGC</given-names></name>
<name><surname>Aspinall</surname><given-names>SM</given-names></name>
<etal/>
</person-group>. <article-title>Effect of processed and red meat on endogenous nitrosation and DNA damage</article-title>. <source>Carcinogenesis</source>. <year>2009</year>;<volume>30</volume>(<issue>8</issue>):<fpage>1402</fpage>-<lpage>1407</lpage>.</citation>
</ref>
<ref id="bibr19-0884533612454885">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Felton</surname><given-names>JS</given-names></name>
<name><surname>Knize</surname><given-names>MG</given-names></name>
<name><surname>Salmon</surname><given-names>CP</given-names></name>
<name><surname>Malfatti</surname><given-names>MA</given-names></name>
<name><surname>Kulp</surname><given-names>KS</given-names></name>
</person-group>. <article-title>Human exposure to heterocyclic amine food mutagens/carcinogens: relevance to breast cancer</article-title>. <source>Environ Mol Mutagen</source>. <year>2002</year>;<volume>39</volume>(<issue>2-3</issue>):<fpage>112</fpage>-<lpage>118</lpage>.</citation>
</ref>
<ref id="bibr20-0884533612454885">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cross</surname><given-names>AJ</given-names></name>
<name><surname>Sinha</surname><given-names>R</given-names></name>
</person-group>. <article-title>Meat-related mutagens/carcinogens in the etiology of colorectal cancer</article-title>. <source>Environ Mol Mutagen</source>. <year>2004</year>;<volume>44</volume>(<issue>1</issue>):<fpage>44</fpage>-<lpage>55</lpage>.</citation>
</ref>
<ref id="bibr21-0884533612454885">
<label>21.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Roberton</surname><given-names>AM</given-names></name>
</person-group>. <article-title>Roles of endogenous substances and bacteria in colorectal cancer</article-title>. <source>Mutat Res</source>. <year>1993</year>;<volume>290</volume>(<issue>1</issue>):<fpage>71</fpage>-<lpage>78</lpage>.</citation>
</ref>
<ref id="bibr22-0884533612454885">
<label>22.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lupton</surname><given-names>JR</given-names></name>
</person-group>. <article-title>Microbial degradation products influence colon cancer risk: the butyrate controversy</article-title>. <source>J Nutr</source>. <year>2004</year>;<volume>134</volume>(<issue>2</issue>):<fpage>479</fpage>-<lpage>482</lpage>.</citation>
</ref>
<ref id="bibr23-0884533612454885">
<label>23.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pearson</surname><given-names>JR</given-names></name>
<name><surname>Gill</surname><given-names>CIR</given-names></name>
<name><surname>Rowland</surname><given-names>IR</given-names></name>
</person-group>. <article-title>Diet, fecal water, and colon cancer: development of a biomarker</article-title>. <source>Nutr Rev</source>. <year>2009</year>;<volume>67</volume>(<issue>9</issue>):<fpage>509</fpage>-<lpage>526</lpage>.</citation>
</ref>
<ref id="bibr24-0884533612454885">
<label>24.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Alexander</surname><given-names>DD</given-names></name>
<name><surname>Cushing</surname><given-names>CA</given-names></name>
</person-group>. <article-title>Red meat and colorectal cancer: a critical summary of prospective epidemiologic studies</article-title>. <source>Obes Rev</source>. <year>2011</year>;<volume>12</volume>(<issue>5</issue>):<fpage>e472</fpage>-<lpage>e493</lpage>.</citation>
</ref>
<ref id="bibr25-0884533612454885">
<label>25.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chan</surname><given-names>DSM</given-names></name>
<name><surname>Lau</surname><given-names>R</given-names></name>
<name><surname>Aune</surname><given-names>D</given-names></name>
<etal/>
</person-group>. <article-title>Red and processed meat and colorectal cancer incidence: meta-analysis of prospective studies</article-title>. <source>PLoS ONE</source>. <year>2011</year>;<volume>6</volume>(<issue>6</issue>):<fpage>e20456</fpage>.</citation>
</ref>
<ref id="bibr26-0884533612454885">
<label>26.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Burkitt</surname><given-names>DP</given-names></name>
</person-group>. <article-title>Colonic-rectal cancer: fiber and other dietary factors</article-title>. <source>Am J Clin Nutr</source>. <year>1978</year>;<volume>31</volume>(<issue>10</issue>)(<supplement>suppl</supplement>):<fpage>S58</fpage>-<lpage>S64</lpage>.</citation>
</ref>
<ref id="bibr27-0884533612454885">
<label>27.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bingham</surname><given-names>SA</given-names></name>
</person-group>. <article-title>Mechanisms and experimental and epidemiological evidence relating dietary fibre (non-starch polysaccharides) and starch to protection against large bowel cancer</article-title>. <source>Proc Nutr Soc</source>. <year>1990</year>;<volume>49</volume>(<issue>2</issue>):<fpage>153</fpage>-<lpage>171</lpage>.</citation>
</ref>
<ref id="bibr28-0884533612454885">
<label>28.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Harris</surname><given-names>PJ</given-names></name>
<name><surname>Ferguson</surname><given-names>LR</given-names></name>
</person-group>. <article-title>Dietary fibre: its composition and role in protection against colorectal cancer</article-title>. <source>Mutat Res</source>. <year>1993</year>;<volume>290</volume>(<issue>1</issue>):<fpage>97</fpage>-<lpage>110</lpage>.</citation>
</ref>
<ref id="bibr29-0884533612454885">
<label>29.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ferguson</surname><given-names>LR</given-names></name>
<name><surname>Chavan</surname><given-names>RR</given-names></name>
<name><surname>Harris</surname><given-names>PJ</given-names></name>
</person-group>. <article-title>Changing concepts of dietary fiber: implications for carcinogenesis</article-title>. <source>Nutr Cancer</source>. <year>2001</year>;<volume>39</volume>(<issue>2</issue>):<fpage>155</fpage>-<lpage>169</lpage>.</citation>
</ref>
<ref id="bibr30-0884533612454885">
<label>30.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Volkers</surname><given-names>N</given-names></name>
</person-group>. <article-title>Beans and bran—fiber data come under fire</article-title>. <source>J Natl Cancer Inst</source>. <year>1999</year>;<volume>91</volume>(<issue>6</issue>):<fpage>496</fpage>-<lpage>497</lpage>.</citation>
</ref>
<ref id="bibr31-0884533612454885">
<label>31.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bingham</surname><given-names>SA</given-names></name>
<name><surname>Norat</surname><given-names>T</given-names></name>
<name><surname>Moskal</surname><given-names>A</given-names></name><etal/>
</person-group>. <article-title>Is the association with fiber from foods in colorectal cancer confounded by folate intake?</article-title> <source>Cancer Epidemiol Biomarkers Prev</source>. <year>2005</year>;<volume>14</volume>(<issue>6</issue>):<fpage>1552</fpage>-<lpage>1556</lpage>.</citation>
</ref>
<ref id="bibr32-0884533612454885">
<label>32.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Aune</surname><given-names>D</given-names></name>
<name><surname>Chan</surname><given-names>DSM</given-names></name>
<name><surname>Lau</surname><given-names>R</given-names></name><etal/>
</person-group>. <article-title>Dietary fibre, whole grains, and risk of colorectal cancer: systematic review and dose-response meta-analysis of prospective studies</article-title>. <source>BMJ</source>. <year>2011</year>;<volume>343</volume>:<fpage>d6617</fpage>.</citation>
</ref>
<ref id="bibr33-0884533612454885">
<label>33.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Alberts</surname><given-names>DS</given-names></name>
<name><surname>Ritenbaugh</surname><given-names>C</given-names></name>
<name><surname>Story</surname><given-names>JA</given-names></name><etal/>
</person-group>. <article-title>Randomized, double-blinded, placebo-controlled study of effect of wheat bran fiber and calcium on fecal bile acids in patients with resected adenomatous colon polyps</article-title>. <source>J Natl Cancer Inst</source>. <year>1996</year>;<volume>88</volume>(<issue>2</issue>):<fpage>81</fpage>-<lpage>92</lpage>.</citation>
</ref>
<ref id="bibr34-0884533612454885">
<label>34.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Aune</surname><given-names>D</given-names></name>
<name><surname>Lau</surname><given-names>R</given-names></name>
<name><surname>Chan</surname><given-names>DSM</given-names></name>
<etal/>
</person-group>. <article-title>Dairy products and colorectal cancer risk: a systematic review and meta-analysis of cohort studies</article-title>. <source>Ann Oncol</source>. <year>2012</year>;<volume>23</volume>(<issue>1</issue>):<fpage>37</fpage>-<lpage>45</lpage>.</citation>
</ref>
<ref id="bibr35-0884533612454885">
<label>35.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wargovich</surname><given-names>M</given-names></name>
<name><surname>Lynch</surname><given-names>P</given-names></name>
<name><surname>Levin</surname><given-names>B</given-names></name>
</person-group>. <article-title>Modulating effects of calcium in animal models of colon carcinogenesis and short-term studies in subjects at increased risk for colon cancer</article-title>. <source>Am J Clin Nutr</source>. <year>1991</year>;<volume>54</volume>(<issue>1</issue>):<fpage>202S</fpage>-<lpage>205S</lpage>.</citation>
</ref>
<ref id="bibr36-0884533612454885">
<label>36.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Van der Meer</surname><given-names>R</given-names></name>
<name><surname>Lapré</surname><given-names>JA</given-names></name>
<name><surname>Govers</surname><given-names>MJAP</given-names></name>
<name><surname>Kleibeuker</surname><given-names>JH</given-names></name>
</person-group>. <article-title>Mechanisms of the intestinal effects of dietary fats and milk products on colon carcinogenesis</article-title>. <source>Cancer Lett</source>. <year>1997</year>;<volume>114</volume>(<issue>1-2</issue>):<fpage>75</fpage>-<lpage>83</lpage>.</citation>
</ref>
<ref id="bibr37-0884533612454885">
<label>37.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wargovich</surname><given-names>MJ</given-names></name>
<name><surname>Baer</surname><given-names>AR</given-names></name>
</person-group>. <article-title>Basic and clinical investigations of dietary calcium in the prevention of colorectal cancer</article-title>. <source>Prev Med</source>. <year>1989</year>;<volume>18</volume>(<issue>5</issue>):<fpage>672</fpage>-<lpage>679</lpage>.</citation>
</ref>
<ref id="bibr38-0884533612454885">
<label>38.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Baron</surname><given-names>JA</given-names></name>
<name><surname>Beach</surname><given-names>M</given-names></name>
<name><surname>Mandel</surname><given-names>JS</given-names></name><etal/>
</person-group>. <article-title>Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group</article-title>. <source>N Engl J Med</source>. <year>1999</year>;<volume>340</volume>(<issue>2</issue>):<fpage>101</fpage>-<lpage>107</lpage>.</citation>
</ref>
<ref id="bibr39-0884533612454885">
<label>39.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Carroll</surname><given-names>C</given-names></name>
<name><surname>Cooper</surname><given-names>K</given-names></name>
<name><surname>Papaioannou</surname><given-names>D</given-names></name>
<name><surname>Hind</surname><given-names>D</given-names></name>
<name><surname>Pilgrim</surname><given-names>H</given-names></name>
<name><surname>Tappenden</surname><given-names>P</given-names></name>
</person-group>. <article-title>Supplemental calcium in the chemoprevention of colorectal cancer: a systematic review and meta-analysis</article-title>. <source>Clin Ther</source>. <year>2010</year>;<volume>32</volume>(<issue>5</issue>):<fpage>789</fpage>-<lpage>803</lpage>.</citation>
</ref>
<ref id="bibr40-0884533612454885">
<label>40.</label>
<citation citation-type="journal">
<collab>North American Menopause Society</collab>. <article-title>The role of calcium in peri- and postmenopausal women: 2006 position statement of the North American Menopause Society</article-title>. <source>Menopause</source>. <year>2006</year>;<volume>13</volume>(<issue>6</issue>):<fpage>862</fpage>-<lpage>877</lpage>; <comment>quiz 878-880</comment>.</citation>
</ref>
<ref id="bibr41-0884533612454885">
<label>41.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Soares</surname><given-names>MJ</given-names></name>
<name><surname>Chan She Ping-Delfos</surname><given-names>W</given-names></name>
<name><surname>Ghanbari</surname><given-names>MH</given-names></name>
</person-group>. <article-title>Calcium and vitamin D for obesity: a review of randomized controlled trials</article-title>. <source>Eur J Clin Nutr</source>. <year>2011</year>;<volume>65</volume>(<issue>9</issue>):<fpage>994</fpage>-<lpage>1004</lpage>.</citation>
</ref>
<ref id="bibr42-0884533612454885">
<label>42.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fedirko</surname><given-names>V</given-names></name>
<name><surname>Tramacere</surname><given-names>I</given-names></name>
<name><surname>Bagnardi</surname><given-names>V</given-names></name><etal/>
</person-group>. <article-title>Alcohol drinking and colorectal cancer risk: an overall and dose-response meta-analysis of published studies</article-title>. <source>Ann Oncol</source>. <year>2011</year>;<volume>22</volume>(<issue>9</issue>):<fpage>1958</fpage>-<lpage>1972</lpage>.</citation>
</ref>
<ref id="bibr43-0884533612454885">
<label>43.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Stickel</surname><given-names>F</given-names></name>
<name><surname>Schuppan</surname><given-names>D</given-names></name>
<name><surname>Hahn</surname><given-names>EG</given-names></name>
<name><surname>Seitz</surname><given-names>HK</given-names></name>
</person-group>. <article-title>Cocarcinogenic effects of alcohol in hepatocarcinogenesis</article-title>. <source>Gut</source>. <year>2002</year>;<volume>51</volume>(<issue>1</issue>):<fpage>132</fpage>-<lpage>139</lpage>.</citation>
</ref>
<ref id="bibr44-0884533612454885">
<label>44.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Schernhammer</surname><given-names>ES</given-names></name>
<name><surname>Giovannucci</surname><given-names>E</given-names></name>
<name><surname>Kawasaki</surname><given-names>T</given-names></name>
<name><surname>Rosner</surname><given-names>B</given-names></name>
<name><surname>Fuchs</surname><given-names>CS</given-names></name>
<name><surname>Ogino</surname><given-names>S</given-names></name>
</person-group>. <article-title>Dietary folate, alcohol and B vitamins in relation to LINE-1 hypomethylation in colon cancer</article-title>. <source>Gut</source>. <year>2010</year>;<volume>59</volume>(<issue>6</issue>):<fpage>794</fpage>-<lpage>799</lpage>.</citation>
</ref>
<ref id="bibr45-0884533612454885">
<label>45.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Giovannucci</surname><given-names>E</given-names></name>
<name><surname>Rimm</surname><given-names>EB</given-names></name>
<name><surname>Ascherio</surname><given-names>A</given-names></name>
<name><surname>Stampfer</surname><given-names>MJ</given-names></name>
<name><surname>Colditz</surname><given-names>GA</given-names></name>
<name><surname>Willett</surname><given-names>WC</given-names></name>
</person-group>. <article-title>Alcohol, low-methionine–low-folate diets, and risk of colon cancer in men</article-title>. <source>J Natl Cancer Inst</source>. <year>1995</year>;<volume>87</volume>(<issue>4</issue>):<fpage>265</fpage>-<lpage>273</lpage>.</citation>
</ref>
<ref id="bibr46-0884533612454885">
<label>46.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Giovannucci</surname><given-names>E</given-names></name>
</person-group>. <article-title>Epidemiologic studies of folate and colorectal neoplasia: a review</article-title>. <source>J Nutr</source>. <year>2002</year>;<volume>132</volume>(<issue>8</issue>)(<supplement>suppl</supplement>):<fpage>2350S</fpage>-<lpage>2355S</lpage>.</citation>
</ref>
<ref id="bibr47-0884533612454885">
<label>47.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pietrzik</surname><given-names>K</given-names></name>
<name><surname>Bailey</surname><given-names>L</given-names></name>
<name><surname>Shane</surname><given-names>B</given-names></name>
</person-group>. <article-title>Folic acid and L-5-methyltetrahydrofolate: comparison of clinical pharmacokinetics and pharmacodynamics</article-title>. <source>Clin Pharmacokinet</source>. <year>2010</year>;<volume>49</volume>(<issue>8</issue>):<fpage>535</fpage>-<lpage>548</lpage>.</citation>
</ref>
<ref id="bibr48-0884533612454885">
<label>48.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kim</surname><given-names>YI</given-names></name>
</person-group>. <article-title>Role of folate in colon cancer development and progression</article-title>. <source>J Nutr</source>. <year>2003</year>;<volume>133</volume>(<issue>11</issue>)(<supplement>suppl 1</supplement>):<fpage>3731S</fpage>-<lpage>3739S</lpage>.</citation>
</ref>
<ref id="bibr49-0884533612454885">
<label>49.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Giovannucci</surname><given-names>E</given-names></name>
<name><surname>Stampfer</surname><given-names>MJ</given-names></name>
<name><surname>Colditz</surname><given-names>GA</given-names></name><etal/>
</person-group>. <article-title>Folate, methionine, and alcohol intake and risk of colorectal adenoma</article-title>. <source>J Natl Cancer Inst</source>. <year>1993</year>;<volume>85</volume>(<issue>11</issue>):<fpage>875</fpage>-<lpage>884</lpage>.</citation>
</ref>
<ref id="bibr50-0884533612454885">
<label>50.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kennedy</surname><given-names>DA</given-names></name>
<name><surname>Stern</surname><given-names>SJ</given-names></name>
<name><surname>Moretti</surname><given-names>M</given-names></name><etal/>
</person-group>. <article-title>Folate intake and the risk of colorectal cancer: a systematic review and meta-analysis</article-title>. <source>Cancer Epidemiol</source>. <year>2011</year>;<volume>35</volume>(<issue>1</issue>):<fpage>2</fpage>-<lpage>10</lpage>.</citation>
</ref>
<ref id="bibr51-0884533612454885">
<label>51.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Figueiredo</surname><given-names>JC</given-names></name>
<name><surname>Mott</surname><given-names>LA</given-names></name>
<name><surname>Giovannucci</surname><given-names>E</given-names></name><etal/>
</person-group>. <article-title>Folic acid and prevention of colorectal adenomas: a combined analysis of randomized clinical trials</article-title>. <source>Int J Cancer</source>. <year>2011</year>;<volume>129</volume>(<issue>1</issue>):<fpage>192</fpage>-<lpage>203</lpage>.</citation>
</ref>
<ref id="bibr52-0884533612454885">
<label>52.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Carroll</surname><given-names>C</given-names></name>
<name><surname>Cooper</surname><given-names>K</given-names></name>
<name><surname>Papaioannou</surname><given-names>D</given-names></name><etal/>
</person-group>. <article-title>Meta-analysis: folic acid in the chemoprevention of colorectal adenomas and colorectal cancer</article-title>. <source>Aliment Pharmacol Ther</source>. <year>2010</year>;<volume>31</volume>(<issue>7</issue>):<fpage>708</fpage>-<lpage>718</lpage>.</citation>
</ref>
<ref id="bibr53-0884533612454885">
<label>53.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kim</surname><given-names>YI</given-names></name>
</person-group>. <article-title>Will mandatory folic acid fortification prevent or promote cancer?</article-title> <source>Am J Clin Nutr</source>. <year>2004</year>;<volume>80</volume>(<issue>5</issue>):<fpage>1123</fpage>-<lpage>1128</lpage>.</citation>
</ref>
<ref id="bibr54-0884533612454885">
<label>54.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>McDowell</surname><given-names>MA</given-names></name>
<name><surname>Lacher</surname><given-names>DA</given-names></name>
<name><surname>Pfeiffer</surname><given-names>CM</given-names></name><etal/>
</person-group>. <article-title>Blood folate levels: the latest NHANES results</article-title>. <source>NCHS Data Brief</source>. <year>2008</year>;(<issue>6</issue>):<fpage>1</fpage>-<lpage>8</lpage>.</citation>
</ref>
<ref id="bibr55-0884533612454885">
<label>55.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Alexander</surname><given-names>BM</given-names></name>
<name><surname>Singh</surname><given-names>P</given-names></name>
<name><surname>Austin</surname><given-names>KJ</given-names></name><etal/>
</person-group>. <article-title>Effect of maternal fatness on fetal steroids and semi-quantitative real-time PCR expression of receptor genes in sheep</article-title>. <source>Anim Reprod Sci</source>. <year>2009</year>;<volume>116</volume>(<issue>1-2</issue>):<fpage>58</fpage>-<lpage>64</lpage>.</citation>
</ref>
<ref id="bibr56-0884533612454885">
<label>56.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Howe</surname><given-names>GR</given-names></name>
<name><surname>Aronson</surname><given-names>KJ</given-names></name>
<name><surname>Benito</surname><given-names>E</given-names></name><etal/>
</person-group>. <article-title>The relationship between dietary fat intake and risk of colorectal cancer: evidence from the combined analysis of 13 case-control studies</article-title>. <source>Cancer Causes Control</source>. <year>1997</year>;<volume>8</volume>(<issue>2</issue>):<fpage>215</fpage>-<lpage>228</lpage>.</citation>
</ref>
<ref id="bibr57-0884533612454885">
<label>57.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mathias</surname><given-names>MM</given-names></name>
<name><surname>Dupont</surname><given-names>J</given-names></name>
</person-group>. <article-title>The relationship of dietary fats to prostaglandin biosynthesis</article-title>. <source>Lipids</source>. <year>1979</year>;<volume>14</volume>(<issue>2</issue>):<fpage>247</fpage>-<lpage>252</lpage>.</citation>
</ref>
<ref id="bibr58-0884533612454885">
<label>58.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wang</surname><given-names>D</given-names></name>
<name><surname>DuBois</surname><given-names>RN</given-names></name>
</person-group>. <article-title>The role of COX-2 in intestinal inflammation and colorectal cancer</article-title>. <source>Oncogene</source>. <year>2009</year>;<volume>29</volume>(<issue>6</issue>):<fpage>781</fpage>-<lpage>788</lpage>.</citation>
</ref>
<ref id="bibr59-0884533612454885">
<label>59.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hardison</surname><given-names>WG</given-names></name>
</person-group>. <article-title>Hepatic taurine concentration and dietary taurine as regulators of bile acid conjugation with taurine</article-title>. <source>Gastroenterology</source>. <year>1978</year>;<volume>75</volume>(<issue>1</issue>):<fpage>71</fpage>-<lpage>75</lpage>.</citation>
</ref>
<ref id="bibr60-0884533612454885">
<label>60.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Van Eldere</surname><given-names>J</given-names></name>
<name><surname>Celis</surname><given-names>P</given-names></name>
<name><surname>De Pauw</surname><given-names>G</given-names></name>
<name><surname>Lesaffre</surname><given-names>E</given-names></name>
<name><surname>Eyssen</surname><given-names>H</given-names></name>
</person-group>. <article-title>Tauroconjugation of cholic acid stimulates 7 alpha-dehydroxylation by fecal bacteria</article-title>. <source>Appl Environ Microbiol</source>. <year>1996</year>;<volume>62</volume>(<issue>2</issue>):<fpage>656</fpage>-<lpage>661</lpage>.</citation>
</ref>
<ref id="bibr61-0884533612454885">
<label>61.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Alexander</surname><given-names>DD</given-names></name>
<name><surname>Cushing</surname><given-names>CA</given-names></name>
<name><surname>Lowe</surname><given-names>KA</given-names></name>
<name><surname>Sceurman</surname><given-names>B</given-names></name>
<name><surname>Roberts</surname><given-names>MA</given-names></name>
</person-group>. <article-title>Meta-analysis of animal fat or animal protein intake and colorectal cancer</article-title>. <source>Am J Clin Nutr</source>. <year>2009</year>;<volume>89</volume>(<issue>5</issue>):<fpage>1402</fpage>-<lpage>1409</lpage>.</citation>
</ref>
<ref id="bibr62-0884533612454885">
<label>62.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Beresford</surname><given-names>SA</given-names></name>
<name><surname>Johnson</surname><given-names>KC</given-names></name>
<name><surname>Ritenbaugh</surname><given-names>C</given-names></name><etal/>
</person-group>. <article-title>Low-fat dietary pattern and risk of colorectal cancer: the Women’s Health Initiative Randomized Controlled Dietary Modification Trial</article-title>. <source>JAMA</source>. <year>2006</year>;<volume>295</volume>(<issue>6</issue>):<fpage>643</fpage>-<lpage>654</lpage>.</citation>
</ref>
<ref id="bibr63-0884533612454885">
<label>63.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fung</surname><given-names>TT</given-names></name>
<name><surname>Hu</surname><given-names>FB</given-names></name>
<name><surname>Wu</surname><given-names>K</given-names></name>
<name><surname>Chiuve</surname><given-names>SE</given-names></name>
<name><surname>Fuchs</surname><given-names>CS</given-names></name>
<name><surname>Giovannucci</surname><given-names>E</given-names></name>
</person-group>. <article-title>The Mediterranean and Dietary Approaches to Stop Hypertension (DASH) diets and colorectal cancer</article-title>. <source>Am J Clin Nutr</source>. <year>2010</year>;<volume>92</volume>(<issue>6</issue>):<fpage>1429</fpage>-<lpage>1435</lpage>.</citation>
</ref>
<ref id="bibr64-0884533612454885">
<label>64.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Byers</surname><given-names>T</given-names></name>
</person-group>. <article-title>Diet and cancer: any progress in the interim?</article-title> <source>Cancer</source>. <year>1988</year>;<volume>62</volume>(<issue>8</issue>)(<supplement>suppl</supplement>):<fpage>1713</fpage>-<lpage>1724</lpage>.</citation>
</ref>
<ref id="bibr65-0884533612454885">
<label>65.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Steinmetz</surname><given-names>KA</given-names></name>
<name><surname>Potter</surname><given-names>JD</given-names></name>
</person-group>. <article-title>Vegetables, fruit, and cancer prevention: a review</article-title>. <source>J Am Diet Assoc</source>. <year>1996</year>;<volume>96</volume>(<issue>10</issue>):<fpage>1027</fpage>-<lpage>1039</lpage>.</citation>
</ref>
<ref id="bibr66-0884533612454885">
<label>66.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Aune</surname><given-names>D</given-names></name>
<name><surname>Lau</surname><given-names>R</given-names></name>
<name><surname>Chan</surname><given-names>DSM</given-names></name>
<etal/>
</person-group>. <article-title>Nonlinear reduction in risk for colorectal cancer by fruit and vegetable intake based on meta-analysis of prospective studies</article-title>. <source>Gastroenterology</source>. <year>2011</year>;<volume>141</volume>(<issue>1</issue>):<fpage>106</fpage>-<lpage>118</lpage>.</citation>
</ref>
<ref id="bibr67-0884533612454885">
<label>67.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Koushik</surname><given-names>A</given-names></name>
<name><surname>Hunter</surname><given-names>DJ</given-names></name>
<name><surname>Spiegelman</surname><given-names>D</given-names></name><etal/>
</person-group>. <article-title>Fruits, vegetables, and colon cancer risk in a pooled analysis of 14 cohort studies</article-title>. <source>J Natl Cancer Inst</source>. <year>2007</year>;<volume>99</volume>(<issue>19</issue>):<fpage>1471</fpage>-<lpage>1483</lpage>.</citation>
</ref>
<ref id="bibr68-0884533612454885">
<label>68.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>van Duijnhoven</surname><given-names>FJ</given-names></name>
<name><surname>Bueno-De-Mesquita</surname><given-names>HB</given-names></name>
<name><surname>Ferrari</surname><given-names>P</given-names></name><etal/>
</person-group>. <article-title>Fruit, vegetables, and colorectal cancer risk: the European Prospective Investigation into Cancer and Nutrition</article-title>. <source>Am J Clin Nutr</source>. <year>2009</year>;<volume>89</volume>(<issue>5</issue>):<fpage>1441</fpage>-<lpage>1452</lpage>.</citation>
</ref>
<ref id="bibr69-0884533612454885">
<label>69.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rayman</surname><given-names>MP</given-names></name>
</person-group>. <article-title>Selenium and human health</article-title>. <source>Lancet</source>. <year>2012</year>;<volume>379</volume>(<issue>9822</issue>):<fpage>1256</fpage>-<lpage>1268</lpage>.</citation>
</ref>
<ref id="bibr70-0884533612454885">
<label>70.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ip</surname><given-names>C</given-names></name>
</person-group>. <article-title>Lessons from basic research in selenium and cancer prevention</article-title>. <source>J Nutr</source>. <year>1998</year>;<volume>128</volume>(<issue>11</issue>):<fpage>1845</fpage>-<lpage>1854</lpage>.</citation>
</ref>
<ref id="bibr71-0884533612454885">
<label>71.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Combs</surname><given-names>GF</given-names><suffix>Jr</suffix></name>
<name><surname>Combs</surname><given-names>SB</given-names></name>
</person-group>. <article-title>The nutritional biochemistry of selenium</article-title>. <source>Annu Rev Nutr</source>. <year>1984</year>;<volume>4</volume>:<fpage>257</fpage>-<lpage>280</lpage>.</citation>
</ref>
<ref id="bibr72-0884533612454885">
<label>72.</label>
<citation citation-type="confproc">
<person-group person-group-type="author">
<name><surname>Patterson</surname><given-names>BH</given-names></name>
<name><surname>Levander</surname><given-names>OA</given-names></name>
</person-group>. <conf-name>Naturally occurring selenium compounds in cancer chemoprevention trials: a workshop summary</conf-name>. <source>Cancer Epidemiol Biomarkers Prev</source>. <year>1997</year>;<volume>6</volume>(<issue>1</issue>):<fpage>63</fpage>-<lpage>69</lpage>.</citation>
</ref>
<ref id="bibr73-0884533612454885">
<label>73.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Willett</surname><given-names>WC</given-names></name>
<name><surname>Polk</surname><given-names>BF</given-names></name>
<name><surname>Morris</surname><given-names>JS</given-names></name><etal/>
</person-group>. <article-title>Prediagnostic serum selenium and risk of cancer</article-title>. <source>Lancet</source>. <year>1983</year>;<volume>2</volume>(<issue>8342</issue>):<fpage>130</fpage>-<lpage>134</lpage>.</citation>
</ref>
<ref id="bibr74-0884533612454885">
<label>74.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Comstock</surname><given-names>GW</given-names></name>
<name><surname>Bush</surname><given-names>TL</given-names></name>
<name><surname>Helzlsouer</surname><given-names>K</given-names></name>
</person-group>. <article-title>Serum retinol, beta-carotene, vitamin E, and selenium as related to subsequent cancer of specific sites</article-title>. <source>Am J Epidemiol</source>. <year>1992</year>;<volume>135</volume>(<issue>2</issue>):<fpage>115</fpage>-<lpage>121</lpage>.</citation>
</ref>
<ref id="bibr75-0884533612454885">
<label>75.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Clark</surname><given-names>LC</given-names></name>
<name><surname>Combs</surname><given-names>GF</given-names><suffix>Jr</suffix></name>
<name><surname>Turnbull</surname><given-names>BW</given-names></name><etal/>
</person-group>. <article-title>Effects of selenium supplementation for cancer prevention in patient with carcinomas of the skin</article-title>. <source>JAMA</source>. <year>1996</year>;<volume>276</volume>:<fpage>1957</fpage>-<lpage>1963</lpage>.</citation>
</ref>
<ref id="bibr76-0884533612454885">
<label>76.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Duffield-Lillico</surname><given-names>AJ</given-names></name>
<name><surname>Reid</surname><given-names>ME</given-names></name>
<name><surname>Turnbull</surname><given-names>BW</given-names></name><etal/>
</person-group>. <article-title>Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial</article-title>. <source>Cancer Epidemiol Biomarkers Prev</source>. <year>2002</year>;<volume>11</volume>(<issue>7</issue>):<fpage>630</fpage>-<lpage>639</lpage>.</citation>
</ref>
<ref id="bibr77-0884533612454885">
<label>77.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Combs</surname><given-names>GF</given-names><suffix>Jr</suffix></name>
<name><surname>Gray</surname><given-names>WP</given-names></name>
</person-group>. <article-title>Chemopreventive agents: selenium</article-title>. <source>Pharmacol Ther</source>. <year>1998</year>;<volume>79</volume>(<issue>3</issue>):<fpage>179</fpage>-<lpage>192</lpage>.</citation>
</ref>
<ref id="bibr78-0884533612454885">
<label>78.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Samaha</surname><given-names>HS</given-names></name>
<name><surname>Hamid</surname><given-names>R</given-names></name>
<name><surname>el-Bayoumy</surname><given-names>K</given-names></name>
<name><surname>Rao</surname><given-names>CV</given-names></name>
<name><surname>Reddy</surname><given-names>BS</given-names></name>
</person-group>. <article-title>The role of apoptosis in the modulation of colon carcinogenesis by dietary fat and by the organoselenium compound 1,4-phenylenebis(methylene)selenocyanate</article-title>. <source>Cancer Epidemiol Biomarkers Prev</source>. <year>1997</year>;<volume>6</volume>(<issue>9</issue>):<fpage>699</fpage>-<lpage>704</lpage>.</citation>
</ref>
<ref id="bibr79-0884533612454885">
<label>79.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>McKenzie</surname><given-names>RC</given-names></name>
<name><surname>Rafferty</surname><given-names>TS</given-names></name>
<name><surname>Beckett</surname><given-names>GJ</given-names></name>
</person-group>. <article-title>Selenium: an essential element for immune function</article-title>. <source>Immunol Today</source>. <year>1998</year>;<volume>19</volume>(<issue>8</issue>):<fpage>342</fpage>-<lpage>345</lpage>.</citation>
</ref>
<ref id="bibr80-0884533612454885">
<label>80.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Beckett</surname><given-names>GJ</given-names></name>
<name><surname>Arthur</surname><given-names>JR</given-names></name>
</person-group>. <article-title>Selenium and endocrine systems</article-title>. <source>J Endocrinol</source>. <year>2005</year>;<volume>184</volume>(<issue>3</issue>):<fpage>455</fpage>-<lpage>465</lpage>.</citation>
</ref>
<ref id="bibr81-0884533612454885">
<label>81.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bellinger</surname><given-names>FP</given-names></name>
<name><surname>Raman</surname><given-names>AV</given-names></name>
<name><surname>Reeves</surname><given-names>MA</given-names></name>
<name><surname>Berry</surname><given-names>MJ</given-names></name>
</person-group>. <article-title>Regulation and function of selenoproteins in human disease</article-title>. <source>Biochem J</source>. <year>2009</year>;<volume>422</volume>(<issue>1</issue>):<fpage>11</fpage>-<lpage>22</lpage>.</citation>
</ref>
<ref id="bibr82-0884533612454885">
<label>82.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Duntas</surname><given-names>LH</given-names></name>
</person-group>. <article-title>Selenium and inflammation: underlying anti-inflammatory mechanisms</article-title>. <source>Horm Metab Res</source>. <year>2009</year>;<volume>41</volume>(<issue>6</issue>):<fpage>443</fpage>-<lpage>447</lpage>.</citation>
</ref>
<ref id="bibr83-0884533612454885">
<label>83.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hu</surname><given-names>YJ</given-names></name>
<name><surname>Diamond</surname><given-names>AM</given-names></name>
</person-group>. <article-title>Role of glutathione peroxidase 1 in breast cancer: loss of heterozygosity and allelic differences in the response to selenium</article-title>. <source>Cancer Res</source>. <year>2003</year>;<volume>63</volume>(<issue>12</issue>):<fpage>3347</fpage>-<lpage>3351</lpage>.</citation>
</ref>
<ref id="bibr84-0884533612454885">
<label>84.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Villette</surname><given-names>S</given-names></name>
<name><surname>Kyle</surname><given-names>JA</given-names></name>
<name><surname>Brown</surname><given-names>KM</given-names></name><etal/>
</person-group>. <article-title>A novel single nucleotide polymorphism in the 3′ untranslated region of human glutathione peroxidase 4 influences lipoxygenase metabolism</article-title>. <source>Blood Cells Mol Dis</source>. <year>2002</year>;<volume>29</volume>(<issue>2</issue>):<fpage>174</fpage>-<lpage>178</lpage>.</citation>
</ref>
<ref id="bibr85-0884533612454885">
<label>85.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rao</surname><given-names>CV</given-names></name>
<name><surname>Cooma</surname><given-names>I</given-names></name>
<name><surname>Rodriguez</surname><given-names>JGR</given-names></name>
<name><surname>Simi</surname><given-names>B</given-names></name>
<name><surname>El-Bayoumy</surname><given-names>K</given-names></name>
<name><surname>Reddy</surname><given-names>BS</given-names></name>
</person-group>. <article-title>Chemoprevention of familial adenomatous polyposis development in the APCmin mouse model by 1,4-phenylene bis(methylene)selenocyanate</article-title>. <source>Carcinogenesis</source>. <year>2000</year>;<volume>21</volume>(<issue>4</issue>):<fpage>617</fpage>-<lpage>621</lpage>.</citation>
</ref>
<ref id="bibr86-0884533612454885">
<label>86.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Reddy</surname><given-names>BS</given-names></name>
<name><surname>Rivenson</surname><given-names>A</given-names></name>
<name><surname>Kulkarni</surname><given-names>N</given-names></name>
<name><surname>Upadhyaya</surname><given-names>P</given-names></name>
<name><surname>El-Bayoumy</surname><given-names>K</given-names></name>
</person-group>. <article-title>Chemoprevention of colon carcinogenesis by the synthetic organoselenium compound 1,4-phenylenebis(methylene)selenocyanate</article-title>. <source>Cancer Res</source>. <year>1992</year>;<volume>52</volume>(<issue>20</issue>):<fpage>5635</fpage>-<lpage>5640</lpage>.</citation>
</ref>
<ref id="bibr87-0884533612454885">
<label>87.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Alberts</surname><given-names>DS</given-names></name>
<name><surname>Martínez</surname><given-names>ME</given-names></name>
<name><surname>Roe</surname><given-names>DJ</given-names></name><etal/>
</person-group>. <article-title>Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas</article-title>. <source>N Engl J Med</source>. <year>2000</year>;<volume>342</volume>:<fpage>1156</fpage>-<lpage>1162</lpage>.</citation>
</ref>
<ref id="bibr88-0884533612454885">
<label>88.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Schatzkin</surname><given-names>A</given-names></name>
<name><surname>Lanza</surname><given-names>E</given-names></name>
<name><surname>Corle</surname><given-names>D</given-names></name><etal/>
</person-group>. <article-title>Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas</article-title>. <source>N Engl J Med</source>. <year>2000</year>;<volume>342</volume>:<fpage>1149</fpage>-<lpage>1155</lpage>.</citation>
</ref>
<ref id="bibr89-0884533612454885">
<label>89.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Greenberg</surname><given-names>ER</given-names></name>
<name><surname>Baron</surname><given-names>JA</given-names></name>
<name><surname>Tosteson</surname><given-names>TD</given-names></name><etal/>
</person-group>. <article-title>A clinical trial of antioxidant vitamins to prevent colorectal adenoma. Polyp Prevention Study Group</article-title>. <source>N Engl J Med</source>. <year>1994</year>;<volume>331</volume>(<issue>3</issue>):<fpage>141</fpage>-<lpage>147</lpage>.</citation>
</ref>
<ref id="bibr90-0884533612454885">
<label>90.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jacobs</surname><given-names>ET</given-names></name>
<name><surname>Jiang</surname><given-names>R</given-names></name>
<name><surname>Alberts</surname><given-names>DS</given-names></name><etal/>
</person-group>. <article-title>Selenium and colorectal adenoma: results of a pooled analysis</article-title>. <source>J Natl Cancer Inst</source>. <year>2004</year>;<volume>96</volume>(<issue>22</issue>):<fpage>1669</fpage>-<lpage>1675</lpage>.</citation>
</ref>
<ref id="bibr91-0884533612454885">
<label>91.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lips</surname><given-names>P</given-names></name>
</person-group>. <article-title>Vitamin D physiology</article-title>. <source>Prog Biophys Mol Biol</source>. <year>2006</year>;<volume>92</volume>(<issue>1</issue>):<fpage>4</fpage>-<lpage>8</lpage>.</citation>
</ref>
<ref id="bibr92-0884533612454885">
<label>92.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>O’Mahony</surname><given-names>L</given-names></name>
<name><surname>Stepien</surname><given-names>M</given-names></name>
<name><surname>Gibney</surname><given-names>MJ</given-names></name>
<name><surname>Nugent</surname><given-names>AP</given-names></name>
<name><surname>Brennan</surname><given-names>L</given-names></name>
</person-group>. <article-title>The potential role of vitamin D enhanced foods in improving vitamin D status</article-title>. <source>Nutrients</source>. <year>2011</year>;<volume>3</volume>(<issue>12</issue>):<fpage>1023</fpage>-<lpage>1041</lpage>.</citation>
</ref>
<ref id="bibr93-0884533612454885">
<label>93.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Garland</surname><given-names>CF</given-names></name>
<name><surname>Garland</surname><given-names>FC</given-names></name>
</person-group>. <article-title>Do sunlight and vitamin D reduce the likelihood of colon cancer?</article-title> <source>Int J Epidemiol</source>. <year>1980</year>;<volume>9</volume>(<issue>3</issue>):<fpage>227</fpage>-<lpage>231</lpage>.</citation>
</ref>
<ref id="bibr94-0884533612454885">
<label>94.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Welsh</surname><given-names>J</given-names></name>
</person-group>. <article-title>Cellular and molecular effects of vitamin D on carcinogenesis</article-title>. <source>Arch Biochem Biophys</source>. <year>2012</year>;<volume>523</volume>(<issue>1</issue>):<fpage>107</fpage>-<lpage>114</lpage>.</citation>
</ref>
<ref id="bibr95-0884533612454885">
<label>95.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Giovannucci</surname><given-names>E</given-names></name>
</person-group>. <article-title>The epidemiology of vitamin D and cancer incidence and mortality: a review (United States)</article-title>. <source>Cancer Causes Control</source>. <year>2005</year>;<volume>16</volume>(<issue>2</issue>): <fpage>83</fpage>-<lpage>95</lpage>.</citation>
</ref>
<ref id="bibr96-0884533612454885">
<label>96.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Huxley</surname><given-names>RR</given-names></name>
<name><surname>Ansary-Moghaddam</surname><given-names>A</given-names></name>
<name><surname>Clifton</surname><given-names>P</given-names></name>
<name><surname>Czernichow</surname><given-names>S</given-names></name>
<name><surname>Parr</surname><given-names>CL</given-names></name>
<name><surname>Woodward</surname><given-names>M</given-names></name>
</person-group>. <article-title>The impact of dietary and lifestyle risk factors on risk of colorectal cancer: a quantitative overview of the epidemiological evidence</article-title>. <source>Int J Cancer</source>. <year>2009</year>;<volume>125</volume>(<issue>1</issue>):<fpage>171</fpage>-<lpage>180</lpage>.</citation>
</ref>
<ref id="bibr97-0884533612454885">
<label>97.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wendel</surname><given-names>M</given-names></name>
<name><surname>Heller</surname><given-names>AR</given-names></name>
</person-group>. <article-title>Anticancer actions of omega-3 fatty acids—current state and future perspectives</article-title>. <source>Anticancer Agents Med Chem</source>. <year>2009</year>;<volume>9</volume>(<issue>4</issue>):<fpage>457</fpage>-<lpage>470</lpage>.</citation>
</ref>
<ref id="bibr98-0884533612454885">
<label>98.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wu</surname><given-names>S</given-names></name>
<name><surname>Feng</surname><given-names>B</given-names></name>
<name><surname>Li</surname><given-names>K</given-names></name><etal/>
</person-group>. <article-title>Fish consumption and colorectal cancer risk in humans: a systematic review and meta-analysis</article-title>. <source>Am J Med</source>. <year>2012</year>;<volume>125</volume>(<issue>6</issue>):<fpage>551</fpage>-<lpage>559</lpage>.<fpage>e5</fpage>.</citation>
</ref>
<ref id="bibr99-0884533612454885">
<label>99.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gupta</surname><given-names>S</given-names></name>
<name><surname>Kim</surname><given-names>J</given-names></name>
<name><surname>Prasad</surname><given-names>S</given-names></name>
<name><surname>Aggarwal</surname><given-names>B</given-names></name>
</person-group>. <article-title>Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals</article-title>. <source>Cancer Metastasis Rev</source>. <year>2010</year>;<volume>29</volume>(<issue>3</issue>):<fpage>405</fpage>-<lpage>434</lpage>.</citation>
</ref>
<ref id="bibr100-0884533612454885">
<label>100.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Khan</surname><given-names>N</given-names></name>
<name><surname>Afaq</surname><given-names>F</given-names></name>
<name><surname>Saleem</surname><given-names>M</given-names></name>
<name><surname>Ahmad</surname><given-names>N</given-names></name>
<name><surname>Mukhtar</surname><given-names>H</given-names></name>
</person-group>. <article-title>Targeting multiple signaling pathways by green tea polyphenol (−)-epigallocatechin-3-gallate</article-title>. <source>Cancer Res</source>. <year>2006</year>;<volume>66</volume>(<issue>5</issue>):<fpage>2500</fpage>-<lpage>2505</lpage>.</citation>
</ref>
<ref id="bibr101-0884533612454885">
<label>101.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Davis</surname><given-names>CD</given-names></name>
<name><surname>Milner</surname><given-names>JA</given-names></name>
</person-group>. <article-title>Gastrointestinal microflora, food components and colon cancer prevention</article-title>. <source>J Nutr Biochem</source>. <year>2009</year>;<volume>20</volume>(<issue>10</issue>):<fpage>743</fpage>-<lpage>752</lpage>.</citation>
</ref>
<ref id="bibr102-0884533612454885">
<label>102.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Schoeller</surname><given-names>DA</given-names></name>
</person-group>. <article-title>Limitations in the assessment of dietary energy intake by self-report</article-title>. <source>Metabolism</source>. <year>1995</year>;<volume>44</volume>(<issue>2</issue>)(<supplement>suppl 2</supplement>):<fpage>18</fpage>-<lpage>22</lpage>.</citation>
</ref>
<ref id="bibr103-0884533612454885">
<label>103.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kipnis</surname><given-names>V</given-names></name>
<name><surname>Subar</surname><given-names>AF</given-names></name>
<name><surname>Midthune</surname><given-names>D</given-names></name><etal/>
</person-group>. <article-title>Structure of dietary measurement error: results of the OPEN biomarker study</article-title>. <source>Am J Epidemiol</source>. <year>2003</year>;<volume>158</volume>(<issue>1</issue>):<fpage>14</fpage>-<lpage>21</lpage>; <comment>discussion 22-26</comment>.</citation>
</ref>
<ref id="bibr104-0884533612454885">
<label>104.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Howard</surname><given-names>RA</given-names></name>
<name><surname>Freedman</surname><given-names>DM</given-names></name>
<name><surname>Park</surname><given-names>Y</given-names></name>
<name><surname>Hollenbeck</surname><given-names>A</given-names></name>
<name><surname>Schatzkin</surname><given-names>A</given-names></name>
<name><surname>Leitzmann</surname><given-names>MF</given-names></name>
</person-group>. <article-title>Physical activity, sedentary behavior, and the risk of colon and rectal cancer in the NIH-AARP Diet and Health Study</article-title>. <source>Cancer Causes Control</source>. <year>2008</year>;<volume>19</volume>(<issue>9</issue>):<fpage>939</fpage>-<lpage>953</lpage>.</citation>
</ref>
<ref id="bibr105-0884533612454885">
<label>105.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gnagnarella</surname><given-names>P</given-names></name>
<name><surname>Gandini</surname><given-names>S</given-names></name>
<name><surname>La Vecchia</surname><given-names>C</given-names></name>
<name><surname>Maisonneuve</surname><given-names>P</given-names></name>
</person-group>. <article-title>Glycemic index, glycemic load, and cancer risk: a meta-analysis</article-title>. <source>Am J Clin Nutr</source>. <year>2008</year>;<volume>87</volume>(<issue>6</issue>):<fpage>1793</fpage>-<lpage>1801</lpage>.</citation>
</ref>
<ref id="bibr106-0884533612454885">
<label>106.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Aune</surname><given-names>D</given-names></name>
<name><surname>Chan</surname><given-names>DS</given-names></name>
<name><surname>Lau</surname><given-names>R</given-names></name><etal/>
</person-group>. <article-title>Carbohydrates, glycemic index, glycemic load, and colorectal cancer risk: a systematic review and meta-analysis of cohort studies</article-title>. <source>Cancer Causes Control</source>. <year>2012</year>;<volume>23</volume>(<issue>4</issue>):<fpage>521</fpage>-<lpage>535</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>